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1. SUMMARY: 
 
Secondary-active membrane transporters drive ions and solutes across the plasma 
membrane using the energy of electrochemical gradients. Their function can be 
experimentally investigated by means of expression cloning in heterologous expression 
systems (e.g. X. laevis oocytes).  
In this work, functional studies on the electrogenic isoforms of sodium-coupled 
phosphate cotransporters (NaPi-IIa/b) have been performed to gain new insights into the 
cotransport mode and the leak mode. The cotransport mode involves recognition of both co-
substrate (Na+) and substrate (Pi) and the translocation of each species according to a defined 
stoichiometry. 3Na+ ions together with 1HPO42- are transported inside the cell, this results in 
a translocation of one net charge per transport cycle per transporter. The leak mode describes 
the action of uncoupled currents. These currents give rise to deviations from the tightly 
coupled electrogenicity and strict stoichiometry between co-substrates and substrates 
expected for ideal secondary-active cotransporters. 
The first study focused on the leak mode of NaPi-IIa/b. The leak current is 
characterized by having a negative reversal potential (Er ~ -20 mV), which is not consistent 
with Na+ ions being the only cation spieces translocated. It was hypothesized that Cl- ions 
participate in the leak, thereby giving the negative Er. The Cl- replacement by several 
different anions also had an effect on non-injected oocytes. We found that the leak current 
was masked by an endogenous anionic component that was sensitive to phosphonoformic 
acid used to quantify the NaPi-II-dependent leak. This result could therefore explain (i) the 
negative Er of the leak and (ii) the variability of the Er, which depends on the donor frog. 
The second study focused on the characterisation of the interaction between lithium 
(Li+) and NaPi-IIa/b. Previous structure-function studies on NaPi-II proteins had indicated a 
possible interaction of Li+ ions, however the underlying mechanism was unclear. A detailed 
functional study on Pi-induced current and on the presteady-state currents was performed to 
determine (i) how many Li+ ions interact with the transporter, (ii) if Li+ could substitute for 
Na+ in the transport cycle and (iii) if Li+ had the same interaction properties of Na+. It was 
observed that Li+ could strongly affect the cotransport voltage-dependence suggesting (i) an 
interaction with NaPi-IIa/b and (ii) a modulation of voltage dependent partial reactions. From 
simultaneous electrophysiology and uptake experiments, we found that at least one Li+ ion 
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could substitute for one Na+ in the transport cycle. The analysis of the presteady-state 
kinetics established that one Li+ can substitute for Na+ before the binding of Pi. 
During my doctoral period, I also contributed to the development of the Cut-Open 
Voltage-Clamp (COVC). This technique allows a very fast voltage clamp (for resolution of 
fast presteady-state relaxations) and it also allows access to the cytoplasmic medium (to 
study intracellular solute interactions). The major improvements concerned the redesign of 
the hardware to ease the external and the internal perfusions and to provide a stable system. 
The new design allowed a precise control of the internal perfusion system by 
micromanipulators and high flow rates for fluid exchange in both internal and external 
perfusions.   
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ZUSAMMENFASSUNG: 
 
Sekundäraktive Membrantransporter treiben Ionen und gelöste Substanzen durch die 
Plasmamembran, indem sie die Energie von elektrochemischen Gradienten nutzen. Deren 
Funktion kann mittels Klonierung in heterologen Expressionssystemen (z.B. in Oozyten von X. 
laevis) experimentell untersucht werden. 
In dieser Arbeit wurden funktionelle Studien an den elektrogenen Isoformen von 
natriumgekoppelten Phosphat-Kotransportern (NaPi-IIa/b) durchgeführt, um neue Erkenntnisse 
über die Kotransport-Mechanismus und Sogenannte Leckprozess zu gewinnen. Der Prozess des 
Kotransports umfasst die Erkennung des Kosubstrats (Na+) und Substrats (Pi) und die 
Translokation jeder Spezies gemäss einer definierten Stöchiometrie. Drei Na+-Ionen zusammen 
mit einem HPO42-Ion werden in die Zelle transportiert, was in einer Verschiebung einer 
Nettoladung pro Transportzyklus pro Transporter resultiert. Der Leckprozess umfasst die 
Präsenz ungekoppelter Ströme. Diese bilden Abweichungen von der eng gekoppelten 
Elektrogenität und strikten Stöchiometrie zwischen den erwarteten Kosubstraten und Substraten 
für die idealen sekundäraktiven Kotransporter. 
Die erste Studie konzentrierte sich auf den Leckmodus von NaPi-Iia/b. Der 
Leckstrom ist durch ein negatives Umkehrpotential charakterisiert (Er ~ -20 mV), was nicht mit 
der Translokation von  Na+-Ionen als einzige Spezies konsistent ist. Es wurde die Hypothese 
aufgestellt, dass Cl--Ionen zum Leckstrom beitragen, was ein negatives Er erklären würde. Das 
Ersetzen von Cl--Ionen durch diverse andere Anionen zeigte auch beim nicht-injizierten Oozyten 
einen Effekt. Wir fanden heraus, dass der Leckstrom von einer endogenen anionischen 
Komponente überlagert wurde, welche auf phosphonoformische Säure, verwendet um den NaPi-
II-abhängigen Strom zu isolieren, reagiert. Diese Erkenntnis könnte demnach (i) das negative Er 
des Lecks und (ii) dessen Variabilität erklären, welche vom Donorfrosch abhängen.  
Die zweite Studie konzentrierte sich auf die Charakterisierung der Interaktion 
zwischen Lithium (Li+) und NaPi-IIa/b. Bisherige Struktur-Funktionsstudien an NaPi-II-
Proteinen hatten eine mögliche Interaktion mit Li+-Ionen angedeutet, wenngleich die 
darunterliegenden Mechanismen unklar waren. Eine detaillierte funktionelle Studie an Pi-
induziertem Strom und an den sogenannten „Presteady-State“ Strömen wurde durchgeführt, um 
zu verstehen (i) wieviele Li+-Ionen mit dem Transporter reagieren, (ii) ob Li+ ein Substituent für 
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Na+ im Transportzyklus ist und ob Li+ dieselben Interaktionseigenschaften wie Na+ hat. Es 
wurde festgestellt, dass Li+ die Spannungsabhängigkeit des Kotransports stark beeinflussen 
konnte, was (i) eine Interaktion mit NaPi-IIa/b und (ii) eine Modulation der 
spannungsabhängigen partiellen Reaktionen suggeriert. Mittels simultanen Elektrophysiologie- 
und Auf nahme experimenten fanden wir heraus, dass im Transportzyklus mindestens ein Li+-
Ion für ein Na+-Ion substituiert werden kann. Die Analyse der „Presteady-State“ Kinetik 
etablierte die Hypothese, dass vor dem binden des Pi ein Li+ für ein Na+ substituiert werden 
kann. 
Während meiner doktoralen Tätigkeit habe ich auch zur Entwicklung des Cut-Open 
Voltage-Clamp (COVC) beigetragen. Diese Technik erlaubt eine sehr schnelle 
Spannungsklemme (mit einer sich den schnellen Presteady-state-Relaxationen annähernden 
Auflösung) und Zugang zum cytoplasmischen Medium (um intrazelluläre Interaktionen von 
gelösten Stoffen zu untersuchen). Die hauptsächlichen Verbesserungen betraffen die 
Neukonzeptionierung der Hardware, um die externe und interne Perfusion zu vereinfachen und 
die Systemstabilität zu gewährleisten. Das neue Konzept erlaubt eine präzise Kontrolle des 
internen Perfusionssystems mittels Mikromanipulatoren und hohe Flussraten des internen und 
externen Flüssigkeitsaustausches. 
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2. INTRODUCTION 
 
Phospholipid membranes create a hydrophobic barrier between the cell interior and its 
external environment, as well as between the interior of the cell (the cytosol) and the internal 
milieu of cellular organelles. However, these membranes alone can neither establish nor 
maintain life. A means of selective transmembrane transport of ions as well as inorganic and 
organic molecules is essential to regulate the constituents of the external and internal 
environment. Membrane transport systems are necessary to fulfill a multitude of essential 
functions such as uptake of nutrients in the intestine, excretion of metabolic products in the 
kidney, nerve signaling in the central nervous system, as well as homeostatic roles such as 
osmoregulation and maintenance of the membrane potential. Furthermore, from a 
thermodynamic point of view, membrane transport proteins establish a way of overcoming the 
otherwise high energetic costs of moving solutes between the two aqueous environments 
separated by the cell membrane. 
 
2.1  MEMBRANE TRANSPORT PROTEINS 
 
 The presence of “pores” in biological membranes has been a topic of debate since the 
nineteenth century. Already in the 1800, “diffusion” through bladder membranes was studied 
(Brücke 1843). The diffusion phenomenon was explained by the presence of microscopic fluid 
filled spaces that could assemble to form tubes in the membrane to allow water molecules to pass 
from one compartment to another. The pore-theory was at the center of discussion and many 
scientists contributed to develop the theory until Widdas in 1952, studying glucose transport in 
the placenta, observed that experimental data obtained by direct and precise control over glucose 
concentration, were not in accord with the diffusion theory through pores (164). Over the next 50 
years, the introduction of many new techniques, such as the use of radioactive tracer assays 
applied to native tissue, vesicle preparations, DNA cloning, heterologous expression and 
advanced electrophysiology (e.g. voltage clamp) techniques, have finally allowed physiologists 
and biophysicists to divide transport mechanisms into two classes: carriers and channels. The 
characteristics of the transport process such as substrate selectivity, as well as stoichiometry of 
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transported molecules have been used to distinguish between these two classes of membrane 
transport proteins (71). 
 
2.1.1 Channels  
 
 An ion channel can be thought of as a pore that spans the membrane and contains a 
water-filled cavity through which the solutes (e.g. ions) can freely diffuse and cross the 
membrane. The passive permeation of ions through their pore is driven by the free energy 
gradients (e.g. electrical and chemical) present across the membrane. The ion movement is 
defined as “downhill” and leads to the dissipation of the potential energy gradient for that 
species. 
In general terms, the family of channels also includes pores, which allow polar solutes 
(e.g. water and glycerol) to cross the lipid bilayer from outside to inside and vice versa, only 
depending on the osmotic and concentration gradient. Most channels (Fig. 2.1) are characterized 
by a relative high transmembrane transport rate (e.g. > 108 ions/s in the case of high conductance 
K+ channels or 109 H2O molecules/s in the case of AQP1) as compared to most carriers 
(typically in the range of 102 -104/s, for details see next section). Another important property of 
channels is their high selectivity for a particular ion or a polar solute. The selectivity of the 
channels is achieved in the pore region by a specialized structure called a “selectivity filter” (71). 
 
 
Figure 2.1 Channels are integral membrane proteins. 
Crystallized bacterial channels are shown to illustrate the different types of intracellular and extracellular domains. 
Channels are characterized by transmembrane α-helices that constitute the permeation pathway or pore. Arrows 
represent the direction of ion movement through the pore. From (86). 
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Kinetics of ion channels describe the switching between two conformational states, 
namely open and closed. Some ion channels can also reach a so-called inactivated closed state 
(e.g. voltage-gated Na+ channels) or a desensitized closed state (e.g. ligand-gated channels) after 
first opening. The occupancy of these closed states depends on the past activation events 
determined by changes in membrane voltage or ligand binding, respectively. Structurally, the 
opening and closing of the channels are provided by “gates” that act simultaneously. The gating 
process can be triggered by different factors such as changes in the membrane potential (e.g. 
voltage-dependent Na+-channels, Nav family), mechanical forces (e.g. Transient Potential 
Channels, TRPV), osmotic tension and pH (e.g. water channels, AQPs) (71). 
 
2.1.2 Carriers 
 
 Carriers are integral membrane proteins that can be considered to function like enzymes 
(82, 87, 117, 165). The cloning of many mammalian and bacterial carriers and more recently, the 
crystallization of bacterial carriers, has revealed detailed 3-D structures and the mechanism by 
which these membrane proteins catalyse the transport of substrates across membranes.  
In contrast to channels, carriers (Fig. 2.2) are able to accumulate solutes (e.g. ions, 
nutrients, amino acids, oligopeptides and monosaccharides) against their gradient. The transport 
process can be primary active, secondary active or facilitative, depending on the energy used 
(19). Two common features of the carriers are (i) the presence of specific substrate binding sites 
and (ii) the ordered binding of the substrates. Furthermore, as indicated above, carriers are 
generally characterized by a lower turnover rate  compared to the ions flux through channels 
(e.g. 36 cycles/s for the Na+-coupled iodide cotransporter (42)). This low turnover can be 
understood in terms of a so-called transport cycle, where a sequence of conformational changes 
is necessary to successively expose the substrate binding sites to the extracellular medium, then 
to the intracellular medium and allow the dissociation of the substrates on the opposite side of 
the membrane (150). The analogy with enzyme kinetic properties has been used to describe the 
transport cycle: e.g. how the carrier transfers its substrates from one side of the membrane to the 
other can be discriminated by pseudo-first order kinetics and by assigning values to backward 
and forward rate constants (146). 
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Figure 2.2 Bacterial carriers are integral membrane proteins. 
Carriers depend on different energy sources to drive transport across the membrane. Arrows depict the direction of 
movement of substrate and co-substrates (86). 
From a structural point of view, it has been proposed that substrates pass through a 
transmembrane permeation pathway, for which the access is regulated by two “gates”, one at 
each side of the membrane (98, 142). The gates are arranged in a way so that both are never 
simultaneously open. This coordination between the internal and the external gates ensures that 
the binding sites are only exposed at one side of the membrane at the time. The mechanism can 
lead to a stoichiometric coupling between the transported substrate and the conformational 
changes that occur during the cycle.  
Based on the above brief overview, channels and carriers appear to be different and are 
easily distinguishable functionally by their ability to dissipate (channels) or accumulate (carriers) 
solutes. Nevertheless, recent discoveries have shed new light on the traditional classification. 
 
2.1.3 Channels in carriers and carriers in channels: breaking the rules 
 
 At the beginning of 1990’s a discrepancy in the channel/carrier classification became 
apparent. A glutamate activated Cl- current was observed in salamander photoreceptor cells with 
a conductance that was considered too small to be attributed to channels and too large to be 
attributed to transporters (96). This discrepancy with the standard model for the electrogenic 
glutamate transporters was explained by the presence of an additional pathway selective to Cl- 
ions associated with the transporter. Mechanistically, it was proposed that the binding of 
glutamate increased the open probability of a Cl- channel intrinsic to the protein (37). After this 
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discovery, similar channel-like behaviors were observed in several other transporters that belong 
to the sodium-coupled neurotransmitter transporter family (Neurotransmitter Sodium Symporters 
family, NSS). For example, glutamate and dopamine cotransporters contain a Cl- channel (28, 
76, 131); serotonin and norephinephrin cotransporters have Na+ and Li+ conductances, 
respectively (58, 124). 
 Another exception to the channel/carrier classification is found in the Chloride Channel 
family (ClC ) family. Recently it was reported that a bacterial homologue of a Cl- channel acts as 
a H+-Cl--antiporter with a strict stoichiometry of 2:1 (Cl-:H+) (2). A single point mutation reverts 
the ClC antiporter properties to channel-like features (39, 41). Yet another example is the Cystic 
Fibrosis Transmembrane conductance Regulator (CFTR), a Cl- channel, which was found to be 
homolog to the ABC transporter family (57).  
 The above examples suggest that the structure of the two main classes of transmembrane 
proteins, channels and carriers, might be more closely related than it was originally thought (3). 
 
2.2 CARRIER CLASSIFICATIONS 
 
 With the increasing number of data-base entries for transport proteins (protein data bank 
as http://cl.sdsc.edu/ce.html, http://www.ncbi.nlm.nih.gov/sites/gquery) and the description of 
functional information concerning transporters, it has become useful to classify these proteins 
according to their intrinsic characteristics. Currently several different classifications are used 
according the various criteria: energetics, function, genes, etc.. The major classifications 
described below.  
 
2.2.1 Classical classifications 
Classification according to transport energetics 
In contrast to passive diffusion of solutes as displayed by channels, the term “active” 
refers a property of transporters to use a source of energy to accumulate solutes. There are three 
sub-classes: primary, secondary and tertiary active. 
Primary active transporters (Fig. 2.3A) uses the hydrolysis of ATP to ADP (adenosine-3-
phosphate to adenosine-2-phosphate) as a source of energy to transport directly solutes across the 
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membrane. The most common examples is the Na+/K+-ATPase which is responsible for 
maintaining cell membrane potential. 
Secondary-active transporters use the electrochemical potential gradient maintained by 
pumps (e.g. Na+ and K+ gradients across the cell-membrane by the Na+/K+-ATPase, acidification 
of synaptic vesicles by the H+-ATPase, Fig. 2.3B) to concentrate solutes (60). For example, the 
Na+-dependent glucose transporter, SGLT1 couples the movement of two Na+ ions down their 
electrochemical gradient to the uphill movement of one glucose molecule into the cell (7, 36).  
Finally, tertiary-active transporters (Fig. 2.3C) are typically exchangers that work in 
partnership with secondary-active cotransporters having a common substrate. The common 
substrate (substrate 2 in Fig. 2.3) is accumulated in the cell by the cotransporter. The chemical 
free energy gained is then used to drive the exchange process and accumulate a third substrate 
(substrate 3 in Fig. 2.3) (e.g. amino acid exchanger for L-cystine/L-Glu (135)). 
 
 
Figure 2.3 Energetics of active transport. 
A. Primary active transporters use the hydrolysis of a high energy phosphate bond to move substrates across the 
membrane; B. Secondary-active transporters use the electrochemical gradient established by primary active systems 
to accumulate substrates; C. Tertiary-active transporters use the accumulated substrates from secondary-active 
transport to exchange substrates. 
 
  
Introduction 
15 
 
Classification according to function 
 Traditionally the functional classification refers to membrane transport proteins 
(excluding primary active transporters) as being either uniporters, symporters or exchangers (Fig. 
2.4). 
Uniporters (e.g. glucose facilitator, GLUT1) use the chemical gradient of the substrate as 
the driving force (19). 
Symporters (or cotransporters) and antiporters (or exchangers) are able to use the 
electrochemical gradient of an ion to transport a solute into the cell. For symporters, the transport 
of both species is in the same direction (e.g. Na+-dependent glucose cotransporter, SGLT). For 
antiporters, the species move in opposite directions (e.g. Na+/H+ exchanger, NHE1) (19). 
  
  
Figure 2.4 Cartoon depicting three types of transport. 
The uniporters allow the diffusion of a solute in one direction depending on the chemical gradient for that solute. 
The symporters mediate the transport of at least two solutes in the same direction. The antiporters exchange at least 
one solute for another across the plasma membrane. 
 
Classifications according to gene product 
 A new nomenclature for transporters was initiated by the Human Genome Organization 
(HUGO) in 2004 (67). SoLute Carrier (SLC) includes 378 transporters and is composed by 51 
families (Fig. 2.5). General information about the transporters included in this classification is 
found in a table available in internet (http://www.bioparadigms.org/slc/menu.asp). This table 
contains different information: the human gene name, the protein name, the predominant 
substrates, the transport type (cotransporters, exchangers, facilitated transporters and orphan 
transporters) as well as the tissue distribution and the sequence accession ID. For example, 
although SLC5 is termed the sodium-glucose cotransporter family (SGLT1, 2, 3, 4), it also 
includes genes that encode for transporters of iodide (Na+/I- cotransporter, NIS) and choline 
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(CHT1) as the members within the SLC family have greater than 20-25% sequence homology to 
each other. 
 
Figure 2.5 The SoLute Carrier (SLC) family. 
Scheme showing a cell with solute carrier (SLC)- and non-SLC- membrane proteins present in the plasma 
membrane and in intracellular compartment. From (67).   
 
A more general classification is available in the Transporter Classification DataBase (TCDB, 
http://www.tcdb.org/). This data-base is approved by the International Union of Biochemistry 
and Molecular Biology and it includes transporters as well as ion channels. It incorporates both 
functional and phylogenic information (132).  
 Another classification is given by Pfam data-base (http://pfam.sanger.ac.uk/) where 
proteins are classified by domains and provide a genetic classification useful for phylogenetic 
studies (45). 
 
2.2.3 Classifications based on 3-D structures 
 
 Substrate Binding Proteins (SBPs) classification is one of the first classifications that 
consider the structure of binding sites (56). It was introduced in 1999 and includes several types 
of transmembrane and soluble proteins that are characterized by having a binding domain for a 
particular substrate. The classification follows structural differences and recently an updated 
classification was proposed (15). The new SBP classification takes into account all crystal 
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structures available at the beginning of 2010. Different sizes and sequences characterize SBPs 
and they can be discriminated by their three-dimensional structural folds. These folds are 
classified into six clusters based on structure similarity. In each cluster, proteins with similar 
structure, but not necessarily with the same ligand, are grouped. For example, cluster D is 
characterized by a scaffold that contains two relative short hinges but the cluster members can 
bind quite different ligands (e.g. phosphate and iron). This classification allows comparing 
proteins from a structural point of view, in particular in terms of common structural motifs. 
 
Folding classification 
 In 2002, the first crystal structure of a secondary-active transporter (proton-driven 
multidrug exporter, AcrB, (116)) was resolved. Since then, a large number of 3-D structures for 
transporters have been successfully obtained. Despite a large variability in transporter structure 
(i.e. number of TransMembrane Domains -TMD-) and function, the repetition of common 
structures in the protein functional core has become evident. Therefore, transporters with a low 
sequence similarity assume the same structural fold. By looking at the available resolved crystal 
structures, at least five major different core folding architectures can be distinguished (21, 48, 
138): (i) LeuTAa fold; (ii) LacY fold; (iii) GltPh fold; (iv) NhaA fold; (v) ATP/ADP carrier fold 
(Fig. 2.6). 
 
Figure 2.6 Membrane topology of transporters with parallel and inverted structural repeats.  
Modified from (21).  
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The presence of repeats, which comprise several contiguous TMDs, has become evident 
from 3-D structures. Parallel or anti-parallel orientations of repeats are related by a pseudo-
symmetry axis that can be perpendicular or parallel to the plane of the membrane. It is thought 
that these structural repeats arise from gene duplication followed by fusion and sequence 
divergence.  
In the LacY fold, representative of the MFS (Major Facilitator Superfamily), two repeats 
have a parallel orientation with respect to the plain of the membrane and const in 6 TMDs, each 
containing 3 TMDs that are anti-parallel suggesting a 3 TMDs ancestral form (Fig. 2.6a). The 
ATP/ADP mitochondrial carrier fold contains three identical units, each composed by 2 TMDs, 
to give a threefold pseudo-symmetric structure (Fig. 2.6b). 
 The other three folds depicted in Fig. 2.6c, 2.6d, 2.6e, are characterized by inverted 
structural repeats with anti-parallel orientation and a pseudo-symmetry axis parallel to the plane 
of the membrane. The GltPh fold shows a 3 TMDs repeat whereas NhA and LeuTAa folds contain 
two 5 TMDs repeats. The majority of secondary-active transporters appear to belong to one of 
the three latest folds structure family. In the next two subsections, the LeuTAa and GltPh folds will 
be described in detail.  
 
Hairpin-like non-transmembrane discontinuous helices 
The GltPh (that is an aspartate transporter) has a core folding that is so-called hairpin-like 
fold and is formed by non-transmembrane discontinuous helices. The folding architecture (Fig. 
2.7c) shows 6 TMDs. They surround the core of the transport machinery composed by two re-
entrant hairpin loops (HP1 and HP2) and transmembrane helix (TM7 and first part of TM8) that 
are orientated in an anti-parallel manner (169). This core folding is a characteristic of the 
glutamate transporters as well as H+/Cl- exchangers (40). 
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Figure 2.7 Architecture of the GltPh fold.  
a. View parallel to the membrane. b. View approximately perpendicular to the membrane. c. Topological model. 
Brown: the hairpin loops that form the binding core of the monomer; pink/green: the inverted motif that protect the 
binding core, yellow: substrate (S) and co-substrates (+). From (91). 
  
Transmembrane discontinuous helices 
The folding architecture that is observed in LeuTAa (the bacterial leucine transporter) is 
named architecture at transmembrane discontinuous helices (Fig. 2.8). Its structure shows a 5+5 
TMDs repeat structure (light orange and light blue triangles in Fig. 2.8c). The functional core of 
the transport machinery is composed of two re-entrant loops (EL4-IL1) (167). The helices that 
span the membrane are orientated in an anti-parallel way. This folding is also found in other 
secondary-active transporters such as vSGLT (vibrio Na-glucose transporter) (43), MhP1 
(benzyl-hydantoin transporter) (163) and BetP (Na-betaine symporter) (130). 
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Figure 2.8 Architecture of the LeuTAa fold.  
a. View parallel to the membrane. b. View approximately perpendicular to the membrane. c. Secondary topology. 
Red, the binding core; green, pink, blue: the two inverted repeats; brown: the pseudo-two-fold loops are shown; 
yellow: substrate (S) and co-substrates (+). From (65). 
 
The unexpected similarity in the folding of these cotransporters suggests common 
properties including transport mechanism, substrate/co-substrate binding sites and 
conformational changes associated with the transport activity.  
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2.3 MODELS OF TRANSPORT MECHANISM 
 
 Before the availability of 3-D structural information, a number of transport models had 
been proposed to explain the transport mechanism in carriers by integration of several functional 
studies (Fig. 2.9):  
(i) the elevator mechanism, proposed for the multidrug transporter AcrB (Fig.2.9a); 
(ii) the alternating access mechanism, originally proposed for Na+/K+ pumps, but also 
applied to cotransporter families (Fig. 2.9b); 
(iii) the facilitated diffusion mechanism through a pore in the membrane (Fig. 2.9c, e.g. 
GLUT1); 
(iv) the alternate gate mechanism where the binding pocket access is regulated by gates 
(Fig. 2.9d, proposed for GltPh transporters).  
 
 
Figure 2.9 Schematic representation of four different types of translocation mechanisms proposed from 
functional studies as well as from recent transporters structures. 
From (142). 
 
The most important models that have emerged to explain the mechanism of secondary-
active transporters are the alternating access model and the single-file model. The alternating 
access model was first proposed in 1966 (78). Thirty years later, the multi-substrate single-file 
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model was described in detail (147) explaining new functional data that could not be simply 
explained with the alternating access model.  
 
2.3.1 Alternating access model 
 
In 1966 O. Jardetzky proposed for the first time a transport mechanism that is now known as 
the “alternating access model” (78). The model could explain the transmembrane transport of 
ions by “chemically activated” pumps such as the Na+/K+-ATPase. It shows a sequence of events 
occurring at every transport cycle. Jardetzky proposed three criteria that a transport protein 
should fulfill:  
- it should contain a cavity (permeation pathway) that could admit the substrate; 
- it should be able to present two different configurations (or two conformations), one in 
which the cavity was open to one compartment and another where the cavity was open to 
the second compartment (i.e. binding sites have to be accessible from only one side of the 
membrane at the time); 
- it should contain binding sites for the substrates in the cavity that differed in affinity for 
the substrates depending on the carrier conformation. 
This model fully explained many of the functional properties of the Na+/K+-ATPase such as a 
fixed stoichiometry (e.g. 3Na+:2K+, which was already established from experimental data 
obtained for the pump expressed in red blood cells (125, 139)). 
Later on, the determination of the fixed stoichiometry of GAT1 (Na+-dependent γ-amino 
butyric acid transporter) in a heterologous expression system (X. laevis oocytes) (105), together 
with comparison between experimental data and model prediction (70) offered compelling 
evidence in favor of the alternating access model applied to cotransporters. From these studies, it 
was possible to predict that ordered partial reactions (or transitional states) have to occur to 
couple the transport of two or more substrates. 
The scheme in Fig. 2.10 shows the conformations of a cotransporter during a complete 
transport cycle. All three original criteria postulated by Jardetzky are fulfilled: the permeation 
pathway is accessible from only one side of the membrane at the time. The cycle starts and ends 
at same state. The transporter has two main conformations: the outward and the inward.  
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Figure 2.10 Alternating access mechanism for a symporter.  
The cartoon shows the conformational transitions which a symporter undergoes 
 during the transport cycle. From (21). 
 
The alternating access model is currently the starting point to describe transport mechanisms of 
many transporters. 
 
2.3.2 Single-File Model 
 
 The multi-substrate single-file transport model (Fig. 2.11) was proposed to take into 
account some of the properties that the alternating access model could not explain: namely 
uncoupled currents and variable stoichiometry (147). This model, considers the transport 
pathway structure as a single alignment of binding sites with ends exposed either to the 
extracellular or intracellular solutions. This structural view was borrowed from ion channel 
models in which the pathway is composed of a series of simultaneously bound ions (71). A 
substrate can be loaded from the solution to the first binding site (Fig. 2.11A). Once a substrate 
occupies the first binding site the “allowed” movements are from the binding site back into the 
solution or from the first to the second binding site (Fig. 2.11B). 
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Figure 2.11 Single-file hopping model. 
A. The substrate can access the first binding site from the extracellular solution. B. When a second substrate 
occupies the first binding site (site 1) the substrate that occupies the second binding site (site 2) cannot move back; 
the only possibility is to go toward the third binding site (site 3). Modified from (147).  
 
The kinetic parameters are the result of all the possible transitions that can take place 
during the substrate transport. Fig. 2.11B depicts the hopping event when two substrates are 
bound in the transporter. Special rules are imposed on sites that are in direct contact with the 
solutions (internal or external). A substrate that is in the solution can “hop” to site 1 only when 
the site is empty, whereas the substrate that occupied the site 1 can always hop into the solution. 
The hopping frequency, given by the rate constants of the transporter kinetic cycle, describes the 
probability of individual hopping events.  
This model describes all the major features of some transporters: leakage current, variable 
stoichiometry, substrate flux coupling and voltage-dependent transients. The major limitation is 
that the model cannot easily account for antiport, countertransport (the ability of the transporter 
to work in reverse mode) and solute exchange that can take place in some transporters (147).  
 Both models are conceptually based on experimental findings and they are important to 
understand the function of carriers. 
 
2.3.3 Confirmation of alternating access model by 3-D structure 
 
 Transporter crystal structures, which have been resolved in the past decades, provide 
compelling evidence in support of the alternating access model. An evidence came from the first 
crystal structure of LeuTAa (167) showing that the binding sites were only exposed to the 
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extracellular side of the membrane. The transporter structure contains a topologically inverted 
repeat of two structural elements (1-5 and 6-10) that are pseudosymmetrical with respect to the 
plane of the membrane (Fig. 2.12). Molecular dynamic (MD) simulations suggest that the 
conformational change of the bundle (TMDs 1-2-6-7) gives rise to the alternatively exposure of 
the binding sites (47).  
The discovery of these features strongly supports the original idea of Jardetzky (78) 
whereby the substrate translocation relies on the binding sites being exposed to only one side of 
the membrane at a time. Moreover, the conformational rearrangement, necessary to allow the 
alternative exposure of binding sites, takes place without disrupting the substrate and co-
substrate binding core in accordance also with the Single-Binding Center Gated Pore model 
(SBCGP), proposed to describe ADP/ATP carrier kinetic (49, 162). 
 
Figure 2.12 Structural asymmetry of repeats in LeuT.  
TMs 1–10 of the LeuT crystal structure (upper left panel) were separated into the two structural repeats (lower left 
panel). The repeats can be superimposed by applying a 180° rotation (From (49)). 
Support for the alternating access model and SBCGP were also founded in the 3-D 
structure of another cotransport: the sodium-benzylhydantoin transport protein (Mhp1) as the 
Mhp1 crystal structures of inward, outward and occluded states have been resolved (140).  
MD simulations describe the main conformational change that occurs during the 
transition from the outward-facing state to the inward-facing state as a rotation of two rigid 
domains (the so-called bundle and hash domains) similarly to a “rocker-switch” mechanism 
(proposed also for LeuTAa). In the MD simulation, the opening and the closing of the “gates”, 
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structurally corresponding to the helices that connect the bundle and the hash domains, is 
synchronized (or coupled) as described for the alternating access model (140). 
Recently, the mechanistic model proposed for the proton/sugar cotransport (LacY) 
confirmed the validity of the alternating access model for the representative of the MFS family. 
This confirms that, also for this cotransporter family, the presence of inverted-domains is a key 
element to allow alternating access to the substrate binding pockets (127).  
 Research in the field of transmembrane proteins has been mainly focused on 
structure/functional characterization of transporters. The crystal structures emerging for many of 
the membrane proteins have increased our understanding of the actual transport process. The 
information obtained from functional and crystallographic data can be now combined to explore, 
in more detail, the transport mechanism of both channels and transporters using molecular 
dynamics simulations. In silico simulations can provide a temporal and spatial resolution of ion 
movements throughout the permeation pathway. This method relies on the determination of 
forces between individual atoms and this relationship with the phospholipid bilayer. 
Accumulation of inaccuracies in the determination of the forces describing the physical 
interactions limit the time of simulations to the microsecond range (86, 97).  
Although these models provide a concept for how the proteins may function, the 
predicted behavior of these models always needs to be confirmed by functional studies.   
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2.4 FUNCTIONAL CHARACTERIZATION OF ELECTROGENIC TRANSPORTERS. 
 
Over the last 50 years, the concepts derived from enzyme kinetics have successfully been 
applied to the characterization of membrane transport via carriers. For example, the movement of 
solutes from one compartment to another across the membrane can be considered as a reaction 
that is catalyzed by transport proteins acting as enzymes. Indeed, a transport system is described 
by some of the following properties for solutes, which are common to enzymatic processes: 
• substrate specificity; 
• apparent affinity for solutes (. ); 
• stoichiometry: a fixed number of solutes are involved in each transport cycle; 
• binding mechanism: interactions on the transporter with solutes can be described as an 
ordered sequence of events; 
• turnover rate: number of transport cycles per unit time; 
• inhibitors and the mechanism of interaction with the transporter: substances that inhibit 
the transport function according to competitive, non-competitive or mixed 
competitive/non-competitive schemes. 
 
2.4.1 Two-Electrode Voltage Clamp (TEVC): a method to study electrogenic 
cotransport 
 
Advances of molecular biology techniques such as cloning and over-expression of a 
specific protein allowed the use of heterologous expression systems to explore protein functions. 
Moreover, the development of electrophysiological techniques, in combination with molecular 
biology, opened new frontiers for the investigations of electrogenic transporters. The main 
requirement to study electrogenic transport processes is to have a means to control the membrane 
potential (Vm) changes due to translocation of charges inside the cell, i.e. to achieve voltage 
clamping of the membrane. Indeed, in absence of Vm control, the driving force for the transport 
would be reduced. The electrogenic partial reactions (the transitions from one state to another of 
the protein that are sensitive to the voltage) would eventually change, over the time, their rate 
constant. Both driving force and time variation of the rate constant would contribute to alter the 
overall transport kinetics. 
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Therefore, electrophysiological techniques to study electrogenic transporters need: 
- a control of the driving force (by controlling Vm); 
- a high temporal resolution measurement of transmembrane charge movement (µs to 
ms range); 
- real-time measurements; 
- a detection of protein activity (by steady-state currents). 
A commonly used heterologous expression system is the X. laevis oocyte. These cells 
have a number of advantages, including ease of handling (a large diameter, 1 mm) and are 
therefore easy to inject with either RNA into the cytoplasm or DNA into the nucleus (20). The 
oocyte translates the exogenous injected cRNA into protein, which is targeted to the plasma 
membrane in the case of membrane transport proteins. 
 The two-electrode voltage clamp (TEVC) technique uses two intracellular 
microelectrodes (Fig. 2.13) that impale the oocyte: one of these measures the intracellular 
membrane potential (Vm) compared to the bath (or extracellular medium). The other delivers 
current (I) to the oocyte. The actual membrane voltage (Vm) is compared with the desired 
potential as defined by the experimenter (Vcmd, which is typically in the range from -200 mV to 
+200 mV). Both signals (Vm and Vcmd) are compared by a differential amplifier that continuously 
corrects any differences between Vm and Vcmd by passing current (via the “I” electrode) into the 
oocyte. This negative feedback arrangement allows changes in membrane conductance to be 
followed in real-time. 
As the membrane potential influences the conformational states of some electrogenic 
membrane proteins, a fast, accurate and homogeneous control of the Vm should be achieved by 
the TEVC. Typically, the TEVC can change the membrane potential of an oocyte with a 
temporal accuracy of 1-2 ms. 
 
 
Figure 2.13 Two-Electrode Voltage-Clamp (TEVC). 
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Electrophysiological techniques offer a fast and indirect method to study membrane 
transport in electrogenic transporters. The recording of movement of ions as a current flow can 
be used to study functional characteristics of electrogenic cotransporters. The following section 
will focus on the functional characterization of electrogenic cotransporters using the TEVC by 
studying two types of experimental conditions: 
(i) steady-state, which gives information about the electrogenic activity under steady state 
where the driving forces and the state variables (e.g. charge translocated) are constant; 
(ii) presteady-state, which gives information about how the system responds to a change 
of state induced by a change in an external variable such as Vm.  
 
2.4.2 Characterization of transport related currents 
 
The transporter-associated currents that can be investigated with the voltage clamp 
technique are: 
- steady-state substrate-induced currents; 
- presteady-state currents; 
- steady-state uncoupled leak currents. 
The majority of the electrogenic transporters, depending on the experimental conditions, 
show all three currents. Nevertheless, some exceptions were observed, for example SLC20 Na+-
dependent Pi co-transporter, PiT-1, shows only transport-induced steady-state current with no 
evidence of uncoupled leak currents (129). 
 
Steady-state substrate-induced currents  
 Steady-state substrate-induced currents are movement of charges across the membrane 
that accompany the transport of substrates. These currents reflect the transport of specific 
substrate and co-substrate (molecules and ions), if we assume a fixed stoichiometric relationship 
between charges and substrates translocated. As example of an electrogenic cotransporter I have 
chosen to illustrate this with published data from the sodium-dependent iodide symporter (NIS, 
SLC5A5). 
Representative data obtained from oocytes expressing NIS are depicted in Fig. 2.14. A 
series of voltage-steps were applied to obtain steady-state current traces in presence of a solution 
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containing Na+ as main cation, (Fig. 2.14A). Application of 500 µM iodide (I-) activates the 
cotransporter (Fig. 2.14B). An increase of the currents in the steady-state region (inset in Fig. 
2.14) is seen when the cotransport is activated. The subtraction of traces recorded in absence of I- 
from the ones obtained in presence of I- gives the net current activated by I-. This calculation 
allows to eliminate the endogenous currents present in both conditions. These steady-state 
currents can be plotted as function of voltage in an I/V plot shown in Fig. 2.14C.  
 
Figure 2.14 Steady-state currents in NIS. 
A. Original recordings from an oocyte expressing the NIS transporter in absence of iodide. The traces were 
recorded at five different membrane potentials as shown in the upper part of the panel. B. Recorded traces obtained 
in presence of 500 µM I-. C. I/V plot representing the transport activation by application of different concentrations 
of substrate (from 1 to 100 µM I-). The curves were obtained by subtracting the steady-state current in absence of 
substrate from the one recorded in presence of the substrate. Modified from (42). 
 
Increasing concentrations of I- in the extracellular solution showed different I/V curves 
(Fig. 2.14C) and it allows the determination of different parameters regarding substrate binding 
and substrate binding order: (i) apparent substrate affinity (. ), (ii) Hill coefficient (nH) and 
(iii) maximum transport rates (Imax). The transport activity (current, I) plotted as a function of 
substrate concentration can be fitted with a form of the Hill equation (Eqn. 2.1): 
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where I0 is the recorded response,  is the maximum predicted response and S is the 
substrate concentration. .  is the apparent affinity constant and it represents the substrate 
concentration at which the response is half of the maximal. In the case of a cotransporter with 
fixed driving substrate (A), this is termed the apparent affinity for substrate S, as its value will 
generally depend on A. 
The Hill coefficient (nH), gives a lower estimation of the number of interacting 
molecules when they bind with positive cooperativity (161). If nH =1 the relationship between I 
and the substrate concentration loses its sigmoidicity and this corresponds to the classical 
Michaelis-Menten kinetics. 
The dependence of  on fixed solute concentrations (or activities) is essential to 
determine the substrate binding order. In fact a reduction in the , caused by changing the 
concentration of one substrate at the time is a strong indication that this substrate is the last to 
bind to the transporter. 
 
Presteady-state currents 
In addition to steady-state currents, it is possible to detect another type of transporter- 
associated current typically observed in absence of the saturating concentrations of substrate. 
These currents, termed presteady-state currents (Fig. 2.15A and B), are transient currents 
recorded in response to rapid changes in the Vm. They arise from intrinsic charge movements 
(charged or polar residues) of the protein in the membrane electrical field (i.e. charge movements 
resolved in the empty carrier) as well as the movement of ions entering the transmembrane 
electrical field and their binding, unbinding to the protein (i.e. Na+ as shown in Fig. 2.15A). 
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Figure 2.15 Presteady-state currents in NIS. 
A. Current traces obtained by perfusing an oocyte expressing NIS with 100 mM Na+ as main cation. B. traces 
obtained by subtraction of capacitative and steady-state components from the total current traces (represented in 
A). C. Q/V relationship. D. τ/V plot showing the two time constants derived from the fitting of traces in A. E. Q/V 
relationship at different [Na+] in absence of substrate. Modified from (42). 
 
The traces in Fig. 2.15A comprise two components: (i) a fast relaxation component that 
represents the charging of the membrane capacitance (τf). The speed of relaxation is determined 
by the voltage-clamp performance. The amount of charge displaced varies linearly with the size 
of the voltage-step and does not depend on the Vm (Fig. 2.15D, open squares); (ii) a slow 
relaxation (τs) component represents the charge movement associated with the transporter and it 
shows a non-linear dependence on the voltage (Fig. 2.15D, filled circles). One method of 
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separating these components involves the application of a double exponential curve fitting 
procedure. The quantification of the charges that move in the membrane electrical field in 
response to voltage-jump can be obtained by integration over time of the transient current. The 
charge-voltage relationships obtained (Q/V, Fig. 2.15C) are further analyzed by fitting with a 
Boltzmann function. This function describes a simple two-state system in which each transporter 
is assumed to have an effective mobile charge (ze) that can be displaced across the whole of the 
transmembrane electrical field (Fig. 2.16): 
 
   " = "#$% +  
'()*
+,(./0(1.23.4)/78
  Eqn. 2.2 
 
where " is the maximum charge translocated, "#$% is the steady-state charge at the 
hyperpolarizing potential limit that depends on the holding potential, 9. is the voltage at which 
50% of the charges have been displaced, z is the apparent valence obtained from the maximum 
slope of the fitted function. “:” is the elementary charge, ; is the Boltzmann’s constant and < is 
the absolute temperature.  
 
 
 
Figure 2.16 Schematic representation of the Boltzmann function used to describe the steady-state distribution of 
mobile charges. 
Parameters obtained by fitting the data with a Boltzmann equation are indicated. 
  
Introduction 
34 
Steady-state uncoupled leak currents  
 Leak or slippage current arises from a deviation in the tightness of the coupled 
electrogenic behavior. The terminology that describes this current is taken from enzymes and 
pumps, where the leak is defined as a property of the membrane (i.e. permeability) and the slip 
concerns the molecule (in our case the transporter) that deviates from the strict dependence on 
the driven and driving substrates (119). Many transporters are characterized by these uncoupled 
currents (see Table 2.1). An important distinction can be made between transport-dependent and 
transport-independent leak currents. 
The transport-dependent leak current is detected in presence of driving and driven 
substrates as a current in excess of that associated with the stoichiometric charge translocation. 
A representative example is the glutamate transporter (EAAT family, SLC1). Glutamate 
transport requires 3 Na+ together with a H+ and counter transport of one K+. In the presence of all 
these ions and the substrate, movement of anions (Cl-) also occurs (160). This leak mode is only 
observed when all the substrates and co-substrates are present in the solution and is due to the 
presence of a ligand gated chloride channel associated with the transporter.  
Transport-independent leak currents are detected in absence of driven substrates and may 
or may not involve the driving substrate. 
The investigation of the transport-independent leak current is often difficult because more 
than one ionic species can contribute to the total leak current. The ions contributing to the leak 
current can be either the same as the ions that preferentially drive cotransport (e.g. SGLT1 a leak  
of Na+ (31, 106)) or different (e.g. GAT1 is characterized by an uncoupled Li+ current (26)). 
Leak current can also be anionic as shown for the sodium-coupled neutral amino acid 
transporter: SNAT2 (174) and EAAT5. In particular, for EAAT5 the appearance of an anionic 
conductance that was larger than that associated with the transport substrate, hinted at the 
presence of a leak mode (8). 
The leak current of the Na-iodide sympoter (NIS) represents a good example of transport-
independent mode. In oocytes expressing NIS it was observed that the perfusion with 100 mM 
Na+ alone induces a large inward current (> 100 nA at -50 mV, Fig. 2.17) with respect to H2O-
injected oocytes (<20 nA at -50 mV). The addition of 500 µM of I- causes a further inward 
directed current (Na+ + I-, Fig. 2.17). The Na+-induced current represents the leak of Na+ in the 
oocytes when NIS is expressed in the membrane. The Na+-leak in NIS was found to be saturable 
with increasing Na+ concentration in the extracellular solution. Therefore, the data were best 
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fitted with the Hill equation to predict the nH = 1, indicating that at least one Na+ ion per cycle 
per transporter contributes to the leak through the transporter.  
 
Figure 2.17 Na+-leak current in NIS. 
Current recorded from a NIS injected oocyte with the membrane potential clamped at -50 mV. The tested solutions 
are shown in the upper part of the figure. 100 mM Na+ indicate the Na+ leak current; 500 µM I- indicate the 
substrate-induced steady-state current. Modified from (42). 
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SLC Gene Name Substrates Type of 
uncoupling 
Selected 
references Coupled Uncoupled 
1 EAAT1,2,3,4,5 Na+/H+/K+/Glu Cl- T (8) 
EAAC1  Na+ L (81) 
ASCT1, 2 Na+/Neutral aa Cl- T (173) 
 
 
5 
SGLT1 Na+/Glucose Na+ L (31, 106) 
NIS Na+/I- Na+ L (42) 
SMIT Na+/myoinositol Na+ L (33) 
SMCT Na+/monocarboxylate Anions L (34) 
CHT Na+/Choline Na+ L (77) 
6 GAT1,4 Na+/Cl-/GABA Li+, Cs+, Cl- L (83, 111) 
SERT Na+/Cl-/K+/5HT Na+,Li+,K+,H+,Cl- L/T (27, 59, 112) 
DAT Na+/Cl-/Dopamine Na+,Li+,K+,H+,Cl- L/T (114, 144) 
11 DMT1 H+/divalent cations H+ L (107) 
13 NaDC Na+/dicarboxylate Na+ L (168) 
15 PepT2 H+/peptides H+ L (30) 
34 NaPi-IIa Na+/Phosphate Na+ L (52) 
 
 
38 
SNAT1 Na+/Neutral aa Na+ L (108) 
SNAT2 Na+/Neutral aa Cl- L (174) 
SNAT3 Na+/Neutral aa K+, H+, Na/H+ 
Exchange Cations 
T 
L 
(136) 
 
Table 2.1 Transporter families show uncoupled leak.  
T: transport-dependent leak and L: transport-independent leak mode. Modified from (6).  
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2.4.3 Stoichiometry determination 
 
To characterize the transport mechanism it is important to estimate the solute 
concentrating ability of the transport system. Ideally, cotransporters should display a fixed 
stoichiometry, i.e. between the number of moles of driving and driven substrates transported. 
Considering the alternating access model for substrate transport, it is easy to imagine that the 
binding sites for the substrates are limited in number. It is therefore useful to establish the 
stoichiometry to develop a transporter kinetic model.  
Several approaches to estimate the stoichiometry are possible:  
(i) Tracer methods use radioactive substrates for both substrates/co-substrates. Samples 
are incubated in a solution containing radioactive solutes; they will be then quantified separately 
for the radioactivity accumulated in the cell in the unit of time. The ratio between the amounts of 
the two species will give the stoichiometry. To use this approach, we assume that flux of driving 
and driven substrates is tightly coupled, i.e. the uncoupled flux (or leak current) in the 
electrogenic transporters is negligible. This method can also be used to establish the 
stoichiometry in both electroneutral and electrogenic transporters (79, 81). 
(ii) Substrate activation method involves the quantification of the substrate flux as 
function of the co-substrate, or activator. Here, the concentration of one of the substrates is 
varied and the transport activity measured with radiotracer assays or by electrophysiology (153). 
The stoichiometry is indirectly estimated from the determination of the Hill coefficient (see 
above Eqn. 2.1). The Hill equation can be used to estimate the minimum number of binding 
molecules that are required to activate the protein (transporter or enzyme) but this only provides 
a measure of the degree of cooperatively during the binding process (161).  
(iii) Simultaneous electrophysiology and radiotracer assays. This technique is applicable 
to electrogenic transport systems and it involves the quantification of charges in combination 
with radiotracer for a single species that are translocated during the transport. If two species are 
transported it is necessary to quantify the substrate/charge ratio for each. The combination of the 
two ratios (i.e. nA/nS, number of moles of driving substrate (A)/ number of moles of driven 
substrate (S)) gives the stoichiometry (22, 38, 42, 50). In NIS, the stoichiometry estimation gave 
a ratio of I-/Q = 0.76 and a Na+/Q = 0.42. The combination of these results gave a ratio of 1.8 
(Na+/I-) suggesting a Na+:I- stoichiometry of 2. The underestimation of the ratio is most likely 
due to the contribution of the leak Na+ current which was not accounted for the determination of 
the Na+/ charge ratio (42). 
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 (iv) in thermodynamic equilibrium techniques, the membrane current is clamped to zero 
and the membrane potential (Vm) is measured while external substrate and cation concentrations 
are varied. The stoichiometry is estimated from the ratio between the changes in Vm when either 
co-substrates or substrates are reduced by half. For this method to be applicable, endogenous 
responses must be small and the leak current negligible (31, 34, 95, 141). 
 
2.4.4 Turnover Rate 
 
The determination of the number of transport cycles per unit time (the turnover rate) is an 
important kinetic parameter because it is an indication of the transport capacity of a transporter. 
Moreover, it gives the upper limit for the prediction of the rate-limiting partial reaction in the 
transport cycle. Under defined conditions (e.g. saturating substrate) and knowing the number of 
active transporters, it is possible to determine the transport turnover rate using steady-state and 
presteady-state currents. The method uses presteady-state charge movements to estimate the 
number of active transporters. The assumption of this method comes from studies made on 
channels where the measure of gating charge was proportional to the number of activated 
channels (71).  
Like the gating charges intrinsic to the voltage-gated channels, we can use the presteady-
state charge movements of electrogenic cotransporters to estimate the number of active 
cotransporters. 
For a given transporter, the steady-state current, the current associated to the transport of 
substrate, can be expressed as:  
      = =  > ? e   Eqn. 2.3 
where N is the number of active transporters, > is the unitary turnover rate (transport cycles per 
unit time), q is the number of charges translocated per cycle and e is the electronic charge (1.602 
10-19 C). 
The number of transporters (N) can then be estimated using presteady-state charge 
measurements:  
    = = B	

C,
   Eqn. 2.4 
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where D is the apparent valence of the moveable charge. " is the total charge that can be 
moved. Both " and z can be found by fitting the presteady-state Q/V data with single a 
Boltzmann function (see above Eqn. 2.2 in section 2.4.2). 
Rearranging Eqns. 2.3 and 2.4 we obtain the turnover rate as: 
      > =  C
E B	

   Eqn. 2.5 
This approach is based on the following assumptions: 
1. Is represents the maximum current mediated by the transporter, it must be recorded in 
saturating substrate concentrations and saturating voltages. 
2. Qmax represents the maximal number of mobile charges. 
3. The number of active transporter determination (N) assumes that z, obtained from the 
Boltzmann fit, represents accurately the apparent displacement charge per carrier.  
In different studies, the apparent valence of the moveable charge, z, was found to be 
underestimated:  e.g. SGLT1(172), GAT1 (62) and NIS (42). For example in NIS, the Boltzmann 
fit gave a z ≈1. By means of freeze-fracture (172), it was possible to count the number of 
particles and estimate the transporter density. Using this method to calculate N the estimation 
gave z ≈3.  
For GAT1, using the Is/Qmax linear regression, the predicted turnover rate was 15.2 
cycles/sec. With freeze-fracture method (172) the turnover rate was ≈4.6 cycles/sec confirming 
the importance of the accuracy in the determination of N (62). Several sources of errors were 
noted in the freeze-fracture method: quantification of particles, determination of Qmax, accuracy 
of membrane area.  
Recently it was shown that also the estimations of turnover rates for SGLT1 (57 s-1 (101) and 
28 s-1 (103)) were not correct when correlated with the particle count obtained by the freeze-
fracture method (172). In this study, a new technique was used to estimate the turnover rate: the 
so-called Ion-Trap Technique (ITT) (18). This technique uses an ion-selective microelectrode 
(ISE) to measure directly the ionic activity. To have a high noise-signal ratio the ISE was pushed 
close to the oocyte surface (5 µm) to isolate a small volume of extracellular solution from which 
the cation and the solute were depleted during transport. The turnover rate of SGLT1 was 
estimated to be 13.3 s-1 in presence of 90 mM Na+ and 5 mM α-methyl-D-glucose (99) the main 
limitation of this method is that high levels of expression are needed to measure the change in 
the ion concentrations in the trap. 
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2.4.5 Cation specificity 
 
The majority of cotransporters use Na+ electrochemical gradient as energy to transport 
substrates across the plasma membrane. Nevertheless, other cations, as Li+ and H+, can substitute 
for Na+ as driving force although changing substrate affinities and transporter rates.  
Illustrative examples are the sodium-coupled glucose transporters (SGLT1) and bacterial 
melibiose (MelB). In absence of Na+ (the preferred co-substrate), can use Li+ and H+ as driving 
force to accumulate substrates into the cell. For these transporters the binding of cations induces 
conformational changes that allow the activation of the sugar transport (73, 152). In SLGT 
expressing oocytes, Li+ or H+ can be used as co-substrates but giving a different apparent affinity 
.
FGHI
and maximal rate 
FGHI
. Fig. 2.18 illustrates steady-state substrate-induced currents 
normalized by the substrate-induced current obtained in presence of Na+. It is evident that both 
H+ and Li+ can activate the transport (activation represented by the substrate-induced current 
curve) albeit with a different voltage-dependence. 
 
 
Figure 2.18 Sugar-induced current/voltage (I/V) relationships.  
Currents induced by 5 mM α-methyl-D-glucoside (αMG) were measured in presence of 100 mM Na+ or Li+, pH 7.5, 
or 100 mM choline chloride, pH 5.5, are plotted against the membrane potential. Modified from (73). 
 
The cation specificity for GABA-transporters is isoform-dependent (46, 63, 113). Protons 
can interact with GAT isoforms in a different manner but they are not able to activate the 
transporter preventing the GABA transport across the membrane. Cations can also influence the 
kinetics of presteady-state relaxations, e.g. Li+ reduces the relaxation time at negative potential in 
GAT1 when Na+ is not present (64). 
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2.5 PHOSPHATE TRANSPORTERS 
 
 This dissertation will focus on the functional properties of a particular secondary-active 
membrane protein: sodium-dependent phosphate transporters (NaPi-II). In particular, certain 
questions regarding the nature of the uncoupled current and the interaction of cations with the 
transporter are addressed. In this chapter, functional properties of NaPi-II will be described in 
detail. 
 
2.5.1 Phosphate homeostasis  
 
To place these transporters in a physiological context a brief overview on phosphate 
homeostasis is presented.  
Phosphorus is an essential element for life: it is found in nucleic acids (DNA and RNA), 
it is important for signal transduction; it is an essential component of the phospholipid bilayers 
and it is involved in energy metabolism (as the energy source in the form of ATP) (13). 
 Phosphorus is widely distributed in the body, in the extracellular fluid (~500 gr.) in the 
inorganic form (phosphate, Pi); it is present in the soft tissues in organic form (~100 gr. as a 
component of phospholipids and phospho-proteins) as well as in the bone matrix (~600 gr.) 
where phosphate is stored as hydroxyapatite (19, 44).  
In humans, dietary intake of Pi amounts to 1400 mg per day, once Pi is absorbed in the 
gut, it reaches the circulation where it is essential to buffer the blood pH. Serum Pi concentration 
varies from 0.8 to 1.5 mM. Finally, all the absorbed phosphate is excreted in the urine (900 
mg/day) and feces (500 mg/day) to give an average balance between intake and excretion (19).  
Pi absorption occurs in the small intestine by active transport process as well as free 
diffusion. Pi excretion occurs in the colon during feces formation as well as in kidneys in during 
urine formation. As kidneys filter around 7000 mg/day of phosphate its reabsorption is essential 
to maintain the correct homeostasis. The first part of the nephron (the proximal tubule) is 
involved in the reabsorption of 80% of the Pi via a secondary-active transport process (19). 
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2.5.2 Renal sodium-coupled phosphate cotransporters  
 
 Pi excretion is regulated by modification of the apical expression of the Na+-coupled 
phosphate cotransporters present in the convoluted proximal tubules (154); these membrane 
proteins are secondary active transporters that use the electrochemical potential gradient of Na+ 
to accumulate Pi inside proximal tubule cells. The pathway responsible for the basolateral exit of 
Pi is not yet known, but it has been hypothesized that the accumulation of Pi inside the cells is 
enough to drive its exit through facilitative membrane proteins by diffusion (Fig. 2.19). 
Proteins from two different gene families mediate the Na+-coupled Pi transport in the 
proximal tubule, namely the Type-II Na+-dependent phosphate cotransporters, SLC34 (NaPi-II) 
and Type-III Na+-dependent phosphate cotransporters, SLC20 (PiT).  
The products of the gene family SLC34 encode three NaPi-II isoforms; two of them are 
present in the proximal tubule: NaPi-IIa (SLC34A1) and NaPi-IIc (SLC34A3). The third isoform 
(NaPi-IIb, SLC34A2) is localized in the small intestine, as well as other epithelia-like tissues e.g. 
in lung and testis ,where is responsible for the active absorption of phosphate (68). 
Gene products of SLC20 family include two isoforms: PiT-1 and PiT-2. These phosphate 
transporters were originally identified as retroviral receptors, namely for the gibbon ape 
leukemia virus (Glvr-1, (120)) and for the rat amphotropic virus (Ram-1, (115)). Their strong 
identity with a phosphate permease from Neurospora crassa (80), was a strong indication that 
they were involved in phosphate transport, which was then shown to be the case by heterologous 
expression (84). The wide distribution (i.e. kidney, brain, heart, liver, muscle, and bone marrow) 
of both PiT-1 and PiT-2 suggests that they play a housekeeping function in several different 
types of cells. Recently, it was reported that PiT-2 (SLC20A2) is present in the brush border 
membrane in proximal tubule and contributes to the overall phosphate reabsorption in the kidney 
(Fig. 2.19) (156).  
The main functional difference between NaPi-II and PiT is that NaPi-II prefers divalent 
phosphate (HPO42-, (32)) whereas PiT prefers monovalent phosphate (H2PO4-, (129)) and hence 
the transport of Pi by the latter is not strongly affected by acidification (see below). This suggests 
that the role of PiT in the proximal tubular cells is to compensate for the strong dependence of Pi 
reabsorption by SLC34 when the glomerular filtrate became acidotic (156). 
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Figure 2.19 NaPi-II localisation. 
Na+-coupled Pi cotransporters are found in the apical membranes of proximal tubular brush border epithelia. 
Transporters are localized in the proximal tubule, specifically the S1, S2 and S3 segments. NaPi-IIc is particularly 
abundant in S3 segment. From (17). 
 
 NaPi-II  family 
 Native brush border membrane preparations were used to demonstrate that phosphate 
transport across the proximal tubule epithelia was mediated by a secondary-active transport 
process (74). Furthermore, the effect of pH variations was studied in “in vivo” experiments (25, 
134). In these early studies it was observed that the presence of Pi caused a variation in the 
membrane potential and therefore the presence of an electrogenic transport mechanism was 
proposed (23, 134). After the cloning of the NaPi-IIa (SLC34A1) transporter (110) it was 
possible to perform functional studies on NaPi-IIa heterologously expressed, e.g. in X. laevis 
oocytes, to define kinetic characteristic of this transporter. Electrogenic cotransport of Pi was 
demonstrated unambiguously for the first time using the TEVC (24, 66). Moreover, some of the 
transport properties (e.g. pH dependence, apparent substrate affinities) previously determined 
using membrane preparations were recapitulated under in vitro conditions, which confirmed the 
role of SLC34 proteins in Pi transport in vivo. 
 Our current knowledge about the structure of NaPi-II in the membrane is based on 
hydrophobicity profiles of the primary structure, site-directed mutagenesis and SCAM 
(Substituted Cysteine Accessibility Method, (5)). These techniques together with structure-
function studies and in vitro transcription/translation investigations (93, 126) allow a more 
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precise topology to be predicted than that obtained from solely hydrophobicity analysis of the 
primary sequence. Information about the 3-D structure of the NaPi-II is still lacking. 
The current model for NaPi-II proposes 12 transmembrane domains (TMDs), 8 of which 
are most likely true membrane spanning TMDs and 4 are forming two so-called re-entrant loops. 
One re-entrant loop is internal (formed by TMDs 3-4) and the other one is external (formed by 
TMDs 8-9). These two re-entrant loops are preserved in all NaPi-IIa/b/c isoforms suggesting that 
they are linked to an essential functional role. According to several studies, these two regions 
form the putative pathway for the transport (88, 89, 94, 126). The N- and C- termini are located 
on the cytoplasmic face and a large extracellular loop (between TMDs 5-6) contains two N-
glycosylation sites (92, 126). This loop contains a critical disulfide bridge that is believed to link 
the two protein regions (from TMD 1-5 and from TMD 6-12). Each of these halves of the protein 
contains regions that are believed to move relative to one another in a complementary manner 
during the transport cycle (158) (Fig. 2.20). 
 
Figure 2.20 Secondary topology for rat NaPi-IIa. 
The 12 transmembrane domains are shown; the light blue boxes highlight the two re-entrant loops. Two N-
glycosylation sites and a disulfide bridge have been identified in the large extracellular loop between TMDs 5-6. 
From (159). 
 
 The electrogenic as well as the electroneutral isoforms preferentially transport divalent 
phosphate (HPO42-), which is present in a ratio of 4:1 with the monovalent form (H2PO4-) at 
physiological pH (pH 7.4). Pi is cotransported together with Na+ with different stoichiometries: 
3Na+:1Pi for the electrogenic NaPi-IIa/b (52) and 2Na+:1Pi for the electroneutral NaPi-IIc (9). 
As already indicated above, Pi transport by NaPi-II is affected by extracellular pH. At low 
pH the transport activity (measured as Pi-induced current under voltage-clamp, IPi) decreases, 
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which suggests that an altered acid-base status might influence the phosphate homeostasis in the 
body (51). Phosphonoformic acid (PFA or foscarnet) was shown in BBMVs to be a competitive 
inhibitor of Na+-driven Pi cotransport (148) and was also shown to be a competitive inhibitor of 
NaPi-IIa expressed in X. laevis oocytes (apparent Ki 3.6 mM) (25). 
 
2.5.3 NaPi-II: electrophysiological characterization  
 By means of heterologous expression of NaPi-IIa/b (electrogenic isoforms) in X. laevis 
oocytes, transport activity studies have been conducted using both radiotracer and voltage-clamp 
techniques, in particular the TEVC. In the presence of external Na+, the application of 1mM Pi 
causes an inwardly directed current. This phosphate-induced current (IPi), can be seen as an 
increased inward current with respect to baseline holding current, Ih (Fig. 2.21). IPi is voltage-
dependent, it is due to one net charge being translocated per transport cycle per transporter and it 
was found to be Na+-dependent with an apparent affinity for Na+ comparable to the value found 
in vesicles experiments (~50 mM) (66). The apparent affinity for Pi is ≤ 0.1 mM and below the 
normal physiological concentrations (phosphate serum level 0.8-1.5 mM). The upward deflection 
of Ih caused by the superfusion of 1 mM PFA is due to the inhibitory effect of this compound on 
electrogenic NaPi-II isoforms. The PFA-sensitive current (IPFA), is believed to be a Na+-leak 
passing though the transporter in absence of Pi (i.e. transport-independent leak mode, section 
2.4.2). 
 
Figure 2.21 Electrophysiological responses of NaPi-IIa under voltage clamped conditions. 
A voltage clamped (-50 mV) oocyte superfused with a solution containing 100 mM of Na+ is successively exposed to 
saturating concentration of 1mM Pi (green) and 3 mM PFA (violet). The predicted electrogenic cotransport activity 
is given by ICot. Modified from (6).  
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In a previous study it was established that the presence of saturating Pi suppresses the 
Na+-leak mode and therefore it was proposed that the leak and cotransport modes are mutually 
exclusive (88). Hence, it was convenient to refer to the true cotransport electrical activity defined 
(ICot) obtained from the sum of the absolute values of IPFA and IPi (Fig 2.21 blue arrow).  
The stoichiometry of electrogenic NaPi-IIa/b was determined from data obtained by 
studying the relationships between the translocated charge (Q) and the substrate (Pi) as well as 
between the charge and the co-substrate (Na+). The ratio between the molar equivalent of charge 
translocated (nQt) and number of moles of Pi (nHPO42-) was established, giving a nQ: nHPO42- ratio of 
1:1 (Fig. 2.22 filled circles). This result alone suggests that one Pi was transported together with 
one charge per transport cycle per transporter. In addition, the ratio between the number of 
moles of Na+ (nNa+) and molar equivalent of charge translocated (nQt) was established. This 
experiment gave nQt: nNa+= 1:3 (Fig. 2.22 open circles). The combination of these two results 
established that the NaPi-IIa/b stoichiometry was 3Na+:1Pi (50). 
 
Steady-state currents 
 
The application of Pi induces an inwardly directed current due to the transport of 3 Na+ 
together with one divalent Pi into the cell (Fig 2.23). By application of a voltage-step protocol, 
the Pi-induced current (IPi) can be recorded over a range of potentials (from -160 mV to +80 
mV). Fig. 2.23A and B show original current traces recoded from oocytes expressing NaPi-IIb. 
To obtain IPi, the traces recorded in 100Na are subtracted from the traces recorded in 100Na + Pi 
 
Figure 2.22 Stoichiometry determination of NaPi-IIa and NaPi-IIb. 
Single oocytes were voltage clamped at -50 mV and superfused with a radioactive solution containing 
either 32P or 22Na. In the same oocyte, the charge, Q, associated with the substrate transport and the 
accumulated amount of radiotracer were calculated. Modified from (159).  
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to eliminate endogenous oocytes currents (Fig. 2.23C). The subtracted current traces are then 
plotted as function of voltage (I/V plot Fig. 2.23D).  
 
 
Figure 2.23 Steady-state substrate-induced current in flNaPi-IIb.  
A: traces recorded in presence of 100 mM NaCl (100Na). B. Traces recorded in presence of 100 mM NaCl and 1 
mM Pi (100Na+Pi). C. Traces obtained by subtraction of A from B. D. I/V plot showing phosphate-induced current 
(IPi) for two Na+ concentrations (squares 100 mM Na+, circles IPi at 50 mM Na+). 
As mentioned above, IPi is Na+-dependent as seen from comparing I/V relationships 
obtained in 100Na (Fig. 2.23D, dark blue symbols) with 50Na (Fig. 2.23D, light blue symbols). 
The voltage-dependence of the IPi is isoform-specific meaning that the kinetic rates are 
different between the isoforms. An illustrative example is depicted in Fig. 2.24, IPi is obtained 
applying voltage-step protocol from -140 mV to +40 mV. NaPi-IIa isoform shows the “S” 
shaped voltage-dependence with rate limiting behavior for potentials more negative than -100 
mV (54).  
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Figure 2.24 Comparison of steady-state Pi-induced current for two NaPi-II isoforms. 
Modified from (54).  
These characteristics suggest that the overall transport cycle includes both electrogenic 
(voltage-dependent) and electroneutral (voltage-independent) transitions.  
 
 Presteady-state relaxations 
 
 An understanding of the overall transport cycle can be gained by examining the behavior 
of the transient currents. This allows us to distinguish electrogenic from electroneutral partial 
reactions as well as characterize electrogenic partial reactions. 
Presteady-state charge movements evoked by the voltage-step protocol (Fig. 2.25) are 
detected in oocytes expressing electrogenic isoforms of NaPi-II. These charge movements are 
dependent on the presence of Na+ in the extracellular medium and are strongly suppressed in 
presence of saturating Pi (55) (see 2.4.2, presteady-state).  
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Figure 2.25 Analysis of presteady-state transients.  
A. Original record of the voltage-step protocol. B. Current traces in response to voltage-step protocol. The arrow 
indicates the presteady-state relaxations due to NaPi-II expression. The red traces represent the slower component 
associated with NaPi-II obtained from the two exponential fit. C Q/V plot from the traces represented in panel B, the 
Boltzmann fit is represented by the red curve. 
 
  
Leak mode 
 
 As already mentioned, a leak mode in the electrogenic NaPi-IIa/b is detectable by 
perfusing a clamped oocyte with a solution containing PFA (see Fig. 2.21). Application of 
voltage-step protocol shows that the voltage-dependence of IPFA matches the voltage-dependence 
found for IPi, this support the evidence that the two currents are associated. IPFA is an apparent 
outwardly directed current with a reversal potential (Er) around -20 mV (Fig. 2.26). Previous 
studies showed that NaPi-II Er follows a Nernstian shift according to the change in Na+ 
concentrations, and confirming the cationic nature of Na+-dependent PFA-sensitive current (52). 
However, the negative Er is not consistent with what would be predicted from the Nernst 
equation for Na+ (i.e. with ~10 mM [Na+]I and 100mM [Na+]O we would predict Er ≈ +60 mV). 
This discrepancy will be discussed in detail in the results chapter. 
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Figure 2.26 NaPi-II leak mode. 
The leak current, IPFA (open squares), is obtained by subtraction of traces recorded in presence of 100Na from 
traces obtained in the presence of 100Na +1 mM PFA. Filled squares represent the IPi from the same oocyte. 
 
 Mechanistically, the translocation of Na+ via the leak pathway can occur by two ways: 
• via a process that is independent of the cotransport cycle;  
• by sharing some partial reactions with the cotransport cycle.  
Important evidence in support of the notion that the leak current was directly associated 
with the NaPi-II protein came from mutagenesis studies on NaPi-IIa (88, 89, 94). Here, novel 
cysteines were introduced in the reentrant loop regions (TMD3-4 and TMD8-9) that were 
thought to be associated with the transport pathway. These cysteines were modified by exposure 
to methanethiosulfonate (MTS) reagents (94) to obtain functional data. For example, if oocytes 
expressing the functional mutant A453C were exposed to increasing concentrations of MTSEA 
(2-aminoethyl methanethiosulfonate hydrobromide), the initially inward directed IPi changed 
sign and became equal to IPFA (Fig. 2.27). Moreover, the magnitude of the leak current increased. 
These effects could be reversed by exposing the oocyte to the reducing agent DTT. This was the 
first suggestion of a shared pathway between cotransport and leak modes (94). 
 
 
Figure 2.27 Effect of application of MTS reagents on electrogenic response. 
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Continuous current record obtained at -50 mV showing the response of the NaPi-IIa A435C mutant to 1 mM Pi 
(filled bars) or 3 mM PFA (open bars). After a control application of Pi and PFA, the substrate and the blocker 
were applied after successively application of MTSEA at the indicated concentrations. Modified from (94). 
 
In another study that focused on first re-entrant loop (TMD3-4) an Ala-Cys substitution at 
site 203 caused an increase of the turnover rate of the leak mode, although for this particular 
mutant, the novel cysteine was not amenable to MTS modification. The characterization of this 
mutant also gave a clue about the Na+-leak functional sites because of the alteration in the 
turnover rate (89). 
The generation of the A203C-S460C mutant confirmed the result obtained with A453C. 
In this double mutant the Pi transport kinetics were comparable to the wild-type (WT), however, 
the Na+-leak was significantly increased: up to six-fold with respect to the WT as for the A203C 
alone. Application of MTSEA modified the Cys 460, which in the single mutant (S460C) 
abolished both IPi and IPFA, The modification leads to the suppression of the IPi and to the  
increase of the IPFA (88). These observations suggested that the substrates (Pi and PFA) were able 
to interact with A203C-S460C after MTS modification but only the leak mode was active (Fig. 
2.28). 
 
Figure 2.28 Properties of the double mutant A203C-S460C.  
Oocytes expressing the construct were voltage clamped at -50 mV and 1 mM Pi or 3 mM PFA was applied as 
indicated. After application of MTSEA, the leak increased and the responses to Pi and PFA were the same. Modified 
from (88).  
 Applications of low concentrations of MTS reagents (5µM) over the time gave an 
important clue about the existing relationship between cotransport and leak modes for the 
A203C-S460C mutant. Cysteine modification by MTS showed a decrease in IPi and 
concomitantly, a corresponding increase of IPFA. The modification of the two current modes was 
reciprocal, and this confirmed that the loss of cotransport activity is directly correlated with the 
gain in the leak mode activity (Fig. 2.29). 
Introduction 
52 
 
Figure 2.29 Leak cotransport relationship in A203C-S460C. 
Relationship between the fraction of leak gained and the cotransport loss at the cumulated time of exposure to 
MTSEA or MTSET. Each symbol corresponds to a single oocyte. Modified from (88). 
 
Taken together, these findings established that the leak is intrinsic in the electrogenic NaPi-II and 
that cotransport mode and leak modes are mutually exclusive (88). 
Further investigations were conducted to understand the mechanism behind the leak 
mode. By determining the activation energy (Ea) used to translocate the substrates it is possible 
to distinguish between the channel-like activity (e.g. Ea ~6 kcal/mol) or a carrier-like uniport Na+ 
pathway (e.g. Ea ~18 kcal/mol) (71). Both IPFA and IPi were very sensitive to temperature 
changes. From calculations of the activation energy the IPi (Ea ~16 kcal/mol) and IPFA (Ea ~11 
kcal/mol) had similar Eas. This result confirms that both leak and cotransport modes are typical 
for enzyme-mediated processes (10). 
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 A kinetic model 
 
 The transport of substrates across the membrane can be represented by a kinetic scheme 
that describes the transport cycle as a sequence of partial reactions that involve substrate binding 
and de-binding, as well as movement of the empty and fully loaded carrier across the membrane.  
For NaPi-IIa/b an eight state kinetic model have been proposed (Fig. 2.30). Five states are 
considered to be “outward” facing states (1, 2a, 2b, 3, 4), corresponding to protein conformations 
where the substrate binding sites are exposed to the extracellular medium. If Na+ is present in the 
extracellular solution, it can bind to the protein and allow a conformational change toward state 
2a. Another binding site for the second Na+ is now accessible from the extracellular solution, 
inducing yet another conformational change moving the protein into the 2b state. The successive 
partial reaction (2b  3) is accomplished by the Pi binding (state 3). The last state of the 
sequence of outward facing partial reactions is reached when also the third Na+ binds to the 
transporter. The 4  5 partial reaction describes the transition between the “outward” facing to 
the “inward” facing states, and allows the translocation of Pi and three Na+ cross the membrane. 
The remaining five states correspond to the “inward” facing conformations (5, 6, 7, 7a, 8). These 
transitions have not yet been characterized because the TEVC technique precludes controlled 
exchange of the intracellular solution.  
 
Figure 2.30 Kinetic scheme of electrogenic NaPi-II.  
See text for details. 
 
The voltage-dependence that characterizes the IPi (steady-state currents) originated from two 
of the partial reactions that precede Pi interaction: 
• the empty carrier moving from inward to outward (8↔1); 
• first Na+ binding partial reaction (1↔2).  
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These two partial reactions give rise to capacitative currents: they involve the movement of 
mobile charges within transmembrane field (charge associated with the protein itself and one 
Na+). Presteady-state relaxations are described by these two conformational changes.  
The leak mode (dotted violet line Fig. 2.31) is represented by the partial reactions 1  2a, 2a 
 7a. The partial reaction 2a  7a corresponds to the release of one Na+ inside the cell. The 
inhibitory effect of PFA is represented as an extra partial reaction (2b  3*, where 3* is the state 
where PFA is bound to the transporter instead of Pi.). This places the protein in a blocked state so 
that the normal cotransport cycle is prevented.  
 
 
 
 
 
  
Introduction 
55 
 
2.6 Open questions 
 
A consideration of our present knowledge of the kinetics and structure-function relationships of 
electrogenic sodium-coupled phosphate cotransporters (NaPi-IIa/b) revealed three unanswered 
questions that I will address in the following sections:  
1. What is the ionic basis for the leak mode in electrogenic NaPi-II transporters? 
2. How does lithium interact with NaPi-IIa/b? 
3. How do substrates interact with NaPi-IIb on the cytosolic side? 
 
1. What is the ionic basis for the leak mode in electrogenic NaPi-II transporters? 
 
 As indicated above, there is compelling experimental evidence that the leak mode in 
NaPi-II is intrinsic to the protein and that leak and cotransport mode are mutually exclusive (88). 
However, one unresolved issue concerning the leak current the possible involvement of anions as 
the underlying reason for the negative reversal potential of IPFA (~-30 mV). If the leak current is 
carried exclusively by Na+ ions, thermodynamic equilibrium predicts a reversal potential 
determined by Nernst equation. Considering that the internal Na+ concentration ([Na+]I) is ~10 
mM and the [Na+]O is 100 mM, the calculated reversal potential (Er) is ~+60 mV. Given that the 
intracellular chloride concentration for a typical oocyte is Cl- ~60 mM and the extracellular is 
[Cl-] ~100mM an Er of ~-20 mV can be predicted. Accordingly, one hypothesis to explain the 
negative Er could be that there is also an anionic permeation pathway associated with 
electrogenic NaPi-IIs as found for other transporters (e.g. EAAT (160)). Together with the Na+ 
permeation, this shift the reversal potential to <0 mV. A detailed study of the effect of anions on 
the leak mode was performed and incorporated as new results in a review on the leak of NaPi-II 
cotransporters (6). 
 
2. How does lithium interact with NaPi-IIa/b cotransport mode? 
 
Lithium (Li+) is well known to interact with cation-driven cotransporters. Li+ can either 
give rise to currents (e.g. GAT-1 (83)) or act as inhibitor of the cotransport (e.g. sodium-
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dependent succinate cotransporter NaDC-1, (166)) or act as a co-substrate in absence of Na+ (e.g. 
PiT-1, (129)). Possible effects of Li+ on NaPi-II kinetics have only be studied indirectly and to a 
limited degree by using voltage-clamp fluorometry (61, 157). Using steady-state,  presteady-state 
and radioactivity functional assays, a complete study of these interactions was performed. 
 
3. How do substrates interact with NaPi-IIb on the cytosolic side? 
 
 The kinetic scheme (Fig. 2.31) describes well the forward cotransport mode of NaPi-II, 
however nothing is known about the partial reactions occurring on the cytosolic side. In a study 
on the electroneutral NaPi-IIc, evidence was presented that this isoform can operate in the 
reverse mode, however the order of substrate interactions was not determined (61). To address 
questions about internal substrate interaction and reverse mode, access to the cytosol is 
necessary, which means that the TEVC technique is not applicable. I therefore decided to exploit 
the potential of the Cut-Open Voltage-Clamp technique (COVC) that allows internal perfusion 
of the oocyte cytosol.  
During my doctoral period, several technical changes were made that led to a significant 
improvement in the internal perfusion system. Moreover, the system now allows rapid 
superfusion of the extracellular face of the oocyte with a much higher degree of mechanical 
stability. The improvements of the technique provide an opportunity to study intracellular Na+ 
interactions on the electrogenic NaPi-II. 
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3. METHODS and RESULTS 
 
3.1 Publications that contribute to this work: 
3.1.1 Paper 1: “The leak mode of type II Na+-Pi cotransporters.” 
Channels (Austin). 2008 Sep 20;2(5). 
Andrini O, Ghezzi C, Murer H, Forster IC. 
Institute of Physiology and Center of Integrative Human Physiology (ZIHP), University 
of Zurich, Zurich, Switzerland. 
Methods used: 
• two-electrode voltage-clamp technique (TEVC); 
• radiolabeled tracer assay; 
• single point mutagenesis; 
• voltage-clamp fluorometry (VCF). 
 
My experimental contribution focused on the study of anionic replacement effect on leak mode. 
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3.1.2 Paper 2: “Lithium interactions with the type II Na+-coupled inorganic 
phosphate cotransporters.” 
Andrini O., Meinild A.K., Ghezzi C., Murer H., Forster I.C. 
Institute of Physiology and Center of Integrative Human Physiology (ZIHP), University 
of Zurich, Zurich, Switzerland. 
  
Methods used: 
• Two-electrode voltage-clamp technique (TEVC); 
• Radiolabled tracer assay; 
• Single point mutagenesis. 
 
I characterized the effect of Li+ ions on cotransport. The functional studies lead to the 
development of a revised kinetic scheme for NaPi-II. 
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Abstract 
Type IIa/b Na+-coupled inorganic phosphate cotransporters (NaPi-IIa/b) are generally considered 
to be exclusively Na+ dependent. Here we show that Li+ can substitute for Na+ as a driving 
cation. We expressed NaPi-IIa/b in X. laevis oocytes and performed two-electrode voltage-clamp 
electrophysiology and uptake assays to investigate the effect of external Li+ on their kinetics. 
Substitution of 50% external Na+ with Li+ reduced the maximum transport rate but increased 
apparent affinity for Pi. Moreover, the steady-state voltage dependence of the Pi-induced current 
was significantly weaker in the presence of external Li+. By means of simultaneous 
electrophysiology and 22Na uptake on single oocytes, we show that Li+ ions can substitute for at 
least one of the 3 Na+ ions necessary for cotransport. To identify which partial reactions in the 
transport cycle involved Li+ interactions we performed presteady-state assays. They provide 
compelling evidence that Li+ ions, in the absence of external Na+ can interact with the empty 
carrier, however the total charge displaced was 70% of that in the presence of Na+ or when 50% 
of the Na+ was replaced by Li+. If Na+ and Li+ were both present, the voltage dependence of the 
mobile charges was shifted in the depolarizing direction, which was also consistent with the 
altered steady-state voltage dependence of phosphate induced current. Our presteady-state data 
suggest that charge movement in the presence of Li+ alone reflects the interaction of a single Li+ 
ion with the transporter, in contrast to 2 Na+ ions when only Na is present. To account for our 
findings, we propose an ordered binding scheme for cotransport in which one Li+ ion can bind 
with high affinity at the putative 1st cation interaction site. This is followed by the cooperative 
binding of one Na+ ion, one divalent Pi anion and a 3rd Na+ ion to complete the loading of the 
carrier before translocation. When Li+ is bound, the backward transitions of voltage dependent 
partial reactions in the cotransport cycle are altered to account for the lower turnover rate. 
 
  
Methods and Results 
72 
Introduction 
Secondary-active cotransporters use the free energy available from downhill cation 
electrochemical gradients to catalyse uphill transport of specific solutes into the cell. The 
majority of mammalian cotransporters use Na+ as their preferred driving cation under 
physiological conditions, yet in some cases other cations (Li+, H+) can substitute for Na+, albeit 
with altered apparent cation and substrate affinities, and transport rates. For example, Li+ or H+ 
can drive glucose transport catalysed by the sodium-coupled glucose cotransporter (SGLT1) (16, 
17) and Li+ can substitute for Na+ as the driving cation of the sodium-coupled dicarboxylate 
transporter (NaDC-1) (23) and the excitatory amino acid transporter (EAAT1) (2). Such cation 
substitutions can have significant clinical consequences. For example, therapeutic doses of orally 
administered LiCl, used to treat bipolar disorder, result in the rapid onset of increased renal 
excretion of Krebs cycle intermediates (30). Typically, the concentration of Li+ in both serum 
and glomerular filtrate is in the mM range. Although this is at least 10-fold smaller than the 
prevailing Na+ concentration, it is sufficient to compete with Na+ for one of the 3 cation binding 
sites postulated for NaDC-1 (23), and thereby inhibit reabsorption. On the other hand, some 
cotransporters show no detectable transport activity if Li+ fully replaces Na+, yet when both 
cations are available, potent stimulation of transport can occur at membrane potentials in the 
physiological range, as reported for the γ-amino acid transporter GAT1 (18, 32). 
Type-II Na+-coupled inorganic phosphate (Pi) cotransporters (NaPi-IIa,c; SLC34A1,A3) 
are both expressed in the apical membrane of mammalian proximal tubule epithelia where they 
mediate Pi reabsorption (7, 21). Although genetically unrelated to NaDC-1, their 3:1 (for 
electrogenic NaPi-IIa) and 2:1 (for electroneutral NaPi-IIc) Na+:Pi stoichiometries imply the 
existence of multiple Na+ binding sites that could also be potential targets for Li+ interaction in 
the kidney. In one of the few reports that has addressed the effects of Li+ on renal Pi handling, it 
appears that Pi clearance and tubular reabsorption are normal in humans undergoing chronic Li+ 
therapy (24), unlike the case for dicarboxylates. Moreover, in two animal studies, the effect of 
high doses of Li+ on Pi handling would appear to result from an indirect action on PTH 
regulation of NaPi-II abundance in the brush border membrane, as opposed to an interaction with 
cation binding sites within the transport protein (1, 31).  
In contrast to the lack of any clinically significant effect of Li+ on renal Pi transport, 
biophysical studies on heterologously expressed NaPi-II proteins in Xenopus oocytes reveal 
direct interactions of Li+ on the protein (13, 28, 29). By labeling the electrogenic isoform 
flounder NaPi-IIb with a fluorophore at functionally important sites, voltage dependence changes 
in fluorescence intensity that depend on the [Li+], offer compelling evidence that before Pi 
binding, one Li+ interacts with the protein. The induced conformational changes, as reflected in 
fluorescence intensity changes, were comparable to those reported for Na+ over the same 
concentration range (28), however no evidence for the cotransport of Li+ was presented. Similar 
Li+-dependent changes in fluorescence emissions were reported for the electroneutral NaPi-IIc 
(13). It was also significant that in that study no change in 32P uptake was observed when 50% of 
the Na+ was replaced with Li+. This finding suggested, at least for the electroneutral NaPi-IIc 
isoform, that Li+ does not readily substitute for Na+ in the complete cotransport cycle.   
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Taken together, these findings prompted us to undertake a rigorous biophysical 
investigation of the effects of Li+ on NaPi-II transport kinetics using electrogenic NaPi-II 
isoforms expressed in X. laevis oocytes. Our findings provide compelling evidence that Li+ ions 
compete with Na+ ions at the cation binding site that is initially occupied by external cations in 
the ordered cotransport cycle. Moreover, we demonstrate that at sufficiently high concentrations, 
one Li+ can substitute for one Na+ to drive cotransport of Pi. These findings offer valuable insight 
into how different cations interact with NaPi-II protein to drive coupled transport.  
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Materials and Methods 
 
Solutions and reagents 
 Three standard extracellular solutions were used, each containing (in mM) KCl, 2; CaCl2, 
1.8; MgCl2, 1; HEPES-TRIS, 10; adjusted to pH 7.4 with either 100 mM NaCl, 100 mM LiCl or 
100 mM choline Cl, and are referred to as 100Na, 100Li or 100Ch solutions, respectively. In 
cation substitution experiments NaCl was equimolarly replaced with either ChCl or LiCl and 
solutions with intermediate extracellular [Na+] and [Li+] were obtained by mixing 100Na with 
100Ch or 100Li in appropriate proportions to maintain the same ionic strength. Pi was added 
from a 1M K2HPO4/ KH2PO4 stock premixed to give pH 7.4. Modified Barth’s solution for 
storing oocytes contained (in mM): NaCl, 88; KCl, 1; CaCl2, 0.41; MgSO4, 0.82; NaHCO3, 2.5; 
Ca(NO3)2, 2; HEPES, 7.5; pH 7.5 adjusted with TRIS and supplemented with 5 mg/l doxycyclin 
and 5 mg/l gentamicin. 
All standard reagents were obtained from either Sigma-Aldrich or Fluka (Buchs, 
Switzerland).  
 
Site-directed mutagenesis and cRNA preparation 
 cDNA encoding wild-type (WT) flounder NaPi-IIb (GenBank/EMBL/DDBJ accession n. 
AAB16821) rat NaPi-IIa and human NaPi-IIa were subcloned into KSM expression vector 
containing the 5’ and 3’ UTRs from Xenopus β-globin to improve its expression in oocytes, 
described in (27). The plasmids were linearized with XbaI (Promega) and used a template for 
synthesis of capped cRNA using Message Machine T3 kit (Ambion).The cDNA preparation for 
the A175C mutant of flNaPi-IIb was done as previously described in (14)  
 
Expression in Xenopus laevis oocytes 
 Female X. laevis frogs were purchased from Xenopus Express (France). Portions of ovaries 
were surgically removed from frogs anesthetized in MS222 (tricaine methansulphonate) and cut 
in small pieces.After suturing the incision the frog was placed in a separate tank for at least 2 
days in order to fully recover from the surgery and returned to a larger tank. A minimum of 8 
weeks were allowed before re-operation on the same animal. All animal handling was in full 
compliance with the regulations and recommendations of the University and Federal Veterinary 
Offices with written approval. Oocytes were typically treated for 45 min with collagenase (crude 
type 1A) 1 mg/ml in 100Na solution (without Ca2+) in presence of 0.1 mg/ml trypsin inhibitor 
type III-O. Healthy stage V-VI oocytes were selected, maintained in modified Barth’s solution at 
16°C and injected with 10 ng of cRNA. Experiments were performed 4-7 days after injection.  
 
Two-electrode Voltage Clamp 
 The standard two-electrode voltage clamp (TEVC) technique was used using either  
Geneclamp (Molecular Devices, Inc., USA); Turbo TEX10 (NPI Electronics, Tamm, Germany) 
or a laboratory built TEVC instrument (4). Oocytes were mounted in a small recording chamber 
(volume: 100µl) and continuously superfused (5ml/min) with the test solution pre-cooled to 
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20°C. For constant voltage recordings, currents were acquired at 20 samples/s and filtered at 10 
Hz (3 dB, 8 pole Bessel characteristic). Faster sampling rates (up to 20k samples/s) were used for 
voltage-step recordings with low-pass filtering adjusted accordingly (typically at 500 Hz).  
 Steady-state Pi activation of electrogenic transporters was determined by varying the Pi 
concentration in presence of the same background solution and subtracting the respective 
currents in the control solution alone from those in control solution+Pi. Steady state Na+ 
activation was similarly determined by subtracting the respective responses in the control 
solution from those in control+Pi and [Pi]=1mM. 
Steady-state Pi-induced currents (IPi) were fit with a form of the modified Hill Equation:
 
    
( )( ) KKSSII HHH nSnnPiiP ++= )(][/][ 5.0max
   (1) 
where [S] is the concentration of variable substrate (Na+ or Pi), IPimax is the maximal Pi-induced 
current, K0.5S  is the apparent affinity constant for substrate S, nH is the Hill coefficient and K is a 
constant that take in account of uncoupled leak effects (3). For Pi activation nH=1 and equation 1 
reduces to a Michaelian form. 
 Presteady-state relaxations were recorded using voltage steps from Vh=-60 mV to 
voltages in the range of -180 to +80 mV. Unless otherwise stated, relaxations were quantified by 
fitting with a two-component exponential function starting approximately 4 ms after the 
commencement of the voltage step to allow the linear components of charge movement arising 
from charging the oocyte capacitance to have fully decayed. The fitted curve was then 
extrapolating back to the time at which 70% of the membrane was charged (typically 1 ms after 
pulse onset), estimated by integrating the capacity transient for a 20 mV step from the holding 
potential. This time point was used as the reference time zero for numerical integration of the 
total relaxation to obtain the charge moved (Q) for a step from the holding potential to the test 
potential. 
 The Q-V data were fitted with a Boltzmann function of the form: 
 
( ))/)(exp(1/ 5.0max kTVVzeQQQ hyp −++=
     (2) 
where V0.5 is the voltage at which the charge is distributed equally between two hypothetical 
states, z is the apparent valency of an equivalent charge that moves through the whole of the 
membrane field, Qmax is the total charge available to move, Qhyp is the charge of the 
hyperpolarizing limit and is a function of Vh, and e, k and T have their usual meanings. 
 
Radiolabelled tracer experiments 
32P uptake assay: Oocytes expressing flNaPi-IIb and not injected oocytes (6-10 
oocytes/group) were first equilibrating in 100Na solution without tracer. After aspiration of this 
solution, oocytes were incubated in 100Na solution containing 1mM cold Pi and 32P (final 
specific activity 10 mCi/mmol, Perkin Elmer, Switzerland). Uptake proceeded for 10 min and 
then oocytes were washed 3 or 4 times with 5 ml of ice-cold 100Ch solution containing 2 mM Pi, 
and lysed individually in 250 µl of 4% SDS. The amount of radioactivity in each oocyte was 
measured by scintillation counting (Tri-Carb 2900TR, Packard). The uptake time was chosen to 
be short enough to assume that initial rate conditions were satisfied so that uptake/unit time is a 
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direct measure of transport velocity, without compromising measurement reliability, based on 
previous studies (19). The data were normalized for the uptake obtained from oocytes expressing 
flNaPi-IIb Wild Type (WT), in standard condition (100Na or 50Na50Ch) as indicated. 
  
Simultaneous voltage-clamp and 22Na uptake: standard TEVC was used as described previously 
(26). The oocyte was impaled and clamped at a constant voltage and than superfused with a 
solution 40Na60Ch or 40Na60Li until a stable base line was reached. The oocyte was exposed to 
the corresponding solution containing 1mM Pi cold and 22Na (final specific activity 1.5 
mCi/mmol, Perkin Elmer, Switzerland) for 10 min. After the base line was returned at the 
starting level the oocyte was removed from the chamber and washed 3 times in 100Ch solution 
ice-cold. This experiment was repeated using a solution containing 20 mM Na+ and 80 mM Li+ 
or 80 mM choline Cl. 
The oocyte was lysed in a vial containing 250 µl of 4% SDS to which scintillation 
cocktail was added. The net charge (Q) was calculated from the current traces by subtracting the 
endogenous holding current and numerically integrating the area under the baseline-corrected 
curve.  Uptake and charge were expressed as their molar equivalents, by assuming monovalency 
for the charge. 
 
Data analysis and software. 
Data analysis was performed with Clampfit V. 10.2 (Molecular Devices, Inc., USA) and 
Prism V. 4.03 (Graphpad Software, La Jolla, USA). Data points are shown as mean+/-sem.  
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Results  
 
The effect of Li+ substitution on 32P uptake in oocytes expressing rat and flounder isoforms 
For oocytes expressing the flounder NaPi-IIb isoforms, replacement of NaCl with 100 
mM LiCl (100Li) gave a small uptake amounting to 3.0±0.1% of that measured in 100Na (Fig. 
1A, upper panel). A similar behavior was observed in oocytes expressing the rat NaPi-IIa 
isoform (data not shown). Non-injected (NI) oocytes from the same donor animals showed no 
significant difference between Li+ and Na+ incubation, which suggested that the small uptake in 
100 mM Li+ for the NaPi-IIa/b expressing oocytes was not an endogenous artifact (Fig. 1A, 
lower panel).  
In a second series of uptake experiments, we replaced 50% of external NaCl with either 
LiCl (50Na50Li) or choline Cl (50Na50Ch) and compared the uptake for each isoform. The 
uptake in the presence of Li+ was reduced by approximately 50% (Fig. 1B) which suggested a 
possible interaction of Li+ with the transporter. The effect of Li+ appeared to be common to all 
electrogenic isoforms, as we obtained similar results using the human NaPi-IIa (data not shown).  
 
Steady-state electrophysiology 
To gain further insight into the underlying mechanism of Li+ ions interactions with NaPi-
II proteins, we used the two-electrode voltage clamp (TEVC) to define the electrical driving 
force and measure the steady-state phosphate induced current (IPi) under different external 
perfusion conditions, in response to 1 mM Pi (pH 7.4) (Fig. 2). All these and subsequent assays 
were performed on oocytes expressing the flounder NaPi-IIb isoform because it gave a more 
robust expression. We also performed control measurements using either the rat or human NaPi-
IIa isoforms and we observed qualitatively similar behavior (data not shown). 
Current-voltage (I-V) data pooled from oocytes expressing the flounder NaPi-IIb were 
normalized to IPi at V= -100 mV to take account of different expression levels and aid 
comparison of the responses for each superfusion condition. As shown in Fig. 2A, 100% 
replacement of Na+ with Li+ gave no significant electrogenic response and this was 
indistinguishable from the electrogenic response to Pi in 100Ch (data not shown). At 
hyperpolarizing potentials, replacement of 25%, 50% or 75% of external Na+ with choline 
caused a concomitant reduction in IPi compared with 100Na, as we have previously reported (6, 
26). The equivalent Li+ substitution further reduced IPi compared to the choline case, which was 
also consistent with the reduced 32P uptake observed for superfusion with 50Na50Li (Fig. 1B).  
A comparison of IPi for the same choline and lithium replacements also revealed that the 
presence of Li+ did not simply result in a dose-dependent scaling of the I-V data as might be 
expected for a simple voltage-independent competitive inhibition of transport function. Instead, 
we found that increasing the external [Li+] also altered the voltage-dependence such that the 
voltage-independent, rate-limiting Pi-induced current normally seen at hyperpolarizing potentials 
now occurred at more depolarizing potentials. For example, with 25Na75Li, IPi was voltage 
independent for V<0 (Fig. 2A right panel).  
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By transposing the data of Fig. 2A at each membrane potential to give the cation 
activation dose-dependence we could compare the effect of equimolar choline (Fig. 2B) or 
lithium (Fig. 2C) replacement. In these experiments the total external monovalent cation strength 
was maintained at ∼100 mM. For choline replacement, these data resembled the typical Na+ 
activation for NaPi-IIb and showed the expected tendency to saturate at high [Na+] (4, 6). In 
contrast, we observed no saturation for equimolar Li+ replacement. At low [Na+] the relative 
change in electrogenic response over the voltage range from -160 to 0 mV was smaller when Li+ 
replaced Na+ than for choline replacement. Moreover, in the former case there was a strong 
activation of the response for [Na+] ≥75 mM, particularly at hyperpolarizing potentials. 
To better understand the underlying mechanism by which Li+ affected the transport 
kinetics, we determined the Pi and Na+ activation characteristics with and without a constant 
[Li+] =50 mM. We chose this concentration to ensure that on the one hand the Li+-effect was 
readily detectable and on the hand to have resolvable currents at low [Pi]. Fig. 3A compares the 
pooled I-V data for Pi-activation with a background of either 50Na50Ch or 50Na50Li. Two 
effects of Li+ substitution were readily apparent: (i) the voltage dependence was suppressed over 
the voltage range assayed (-140 mV to 0 mV) and (ii) IPi showed saturation at a lower [Pi] 
compared with superfusion in 50Na50Ch. These effects were better visualized by transposing the 
data (Fig. 3B). We then fit these data with the Michaelis-Menten equation (Eqn 1, with nH = 1) to 
estimate the maximum Pi-induced current (IPimax) and the apparent affinity constant for Pi (K0.5Pi).  
The predicted IPi
max
 plotted as a function of V (Fig. 3C) confirmed the weaker voltage 
dependence for 50Na50Li for V<0 and at the hyperpolarizing extreme, the maximum predicted 
electrogenic transport rate was significantly reduced compared to the 50Na50Ch case. At 
strongly hyperpolarizing potentials, the predicted K0.5Pi (Fig. 3D) for the 3 superfusion conditions 
was similar, however the data sets deviated from one another as V became more polarized. For 
50Na50Li, K0.5Pi decreased with depolarization, which implied that the apparent Pi affinity 
increased, compared to superfusion with either 100Na or 50Na50Ch, for which we observed the 
opposite trend.  
  We next compared the effect of Li+ on Na+ activation of cotransport by determining 
IPiwhile varying [Na
+] with 50 mM Li+ present in all solutions (Fig. 4). To quantify the Na+-
activation, we used 6 Na+ concentrations in the range 3 mM to 100 mM. The pooled, normalized, 
I-V data for this experiment showed the weak voltage dependence for all [Na+] and saturation at 
high [Na+] (Fig. 4A). When these data where transposed (Fig. 4B), we observed no sigmoidicity 
at low [Na+] in contrast to the normal behavior for all electrogenic NaPi-IIa/b isoforms when 
equimolar choline replaced Na+ (e.g. (4, 6, 9, 26)). This can be readily seen when the data 
obtained from a representative oocyte expressing flNaPi-IIb are superimposed (shown for a 
membrane potential =-100mV) (Fig. 4B). The fit using Eqn. 1 with free parameters yielded Hill 
coefficients (nH) that were close to unity (Fig. 4C) over the voltage range investigated and 
contrasted with representative data for choline substitution for which nH>1. Moreover, the 
apparent affinity constant for Na+ activation (K0.5Na) in the presence of 50 mM Li+ was smaller 
compared with the Li+-free case over the range of test potentials (Fig. 4D). Finally, as expected, 
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the predicted IPi
max
 showed less voltage dependence than in the Li+-free case and at V=0, IPi
max
 
was independent of Li+ (Fig. 4E). 
For the complementary experiment (Fig. 5), we maintained [Na+] = 50 mM and varied 
[Li+] from 0 to 75 mM. In this experiment, increasing external [Li+] caused a dose-dependent 
inhibition of IPi over the entire experimental voltage range (Fig. 5A). The transposed data (Fig. 
5B) revealed that at high [Li+] the predicted IPi asymptoted to a constant level that depended 
weakly on V. These data were best fit using the Michaelian form of Eqn 1 (nH=1) with a variable 
offset to take account of the electrogenic response at [Li+]=0.. The predicted apparent Michaelis 
constant for the inhibition (K0.5Li) showed strong voltage dependence and decreased at 
hyperpolarizing potentials (Fig 5D). 
 
Li+ ions and transport stoichiometry 
The preceding results established that Li+ interacted with NaPi-IIb in the presence of Na+ 
to alter the maximum transport rate and apparent affinities for Pi and Na+. That significant 
electrogenic activity remained even for high [Li+] indicated that Li+ did not simply compete for 
occupancy of Na+ interaction sites and thereby block electrogenic, Na+-driven cotransport. One 
possible interpretation of these data could be that one or more Li+ ions substituted for Na+ and 
were cotransported, but possibly at a lower turnover rate than with Na+ alone, consistent with our 
uptake data (Fig. 1A). To test this hypothesis, we performed simultaneous 22Na uptake and 
recording, under voltage clamp, of IPi from individual oocytes as previously described (9, 11, 26) 
(see Materials and Methods). This allowed the determination of the ratio of number of moles of 
Na+ (nNa+) to the molar equivalent of charge translocated (nQt) for individual oocytes. If indeed 
Li+ substituted for Na+ as a driving cation, we would predict that the 3:1 cotransport 
stoichiometry, given by the ratio nNa+:nHPO42- (where nHPO42- is the number of moles of divalent 
Pi transported) would be reduced. Moreover, this decrease should depend on the relative 
availability of each cation. On the other hand, if bound Li+ prevented the completion of the 
cotransport cycle for a given fraction of transporters, the nNa+:nQt ratio should remain 
unchanged. Fig. 6 shows the combined results of this assay with a fixed [Na+] = 20 mM or 40 
mM and with [Li+] and [Ch] =80 mM, or 60 mM, respectively. As previously shown (9, 26), 
when Na+ was the only cation interacting with NaPi-II the nNa+:nQt ratio was close to 3:1 and this 
was independent of the external [Na+] (Fig. 6A). When Li+ was substituted for choline, there was 
a significant reduction in nNa+:nQt for 40Na60Li from 3.1±0.5 to 2.2±0.13 (Students t-test, 
p<0.01) and this was further reduced from 2.8±0.18 to 1.6±0.23 with 20Na80Li (Students t-test 
p<0.004) (Fig. 6B). 
These findings established that Li+ reduced the nNa+:nQt ratio and suggested that Li+ ions 
may substitute for Na+ ions in the transport cycle.   
 
Na+- and Li+-dependence of presteady-state kinetics 
 The steady-state findings indicate that Li+ ions alter the steady-state voltage dependence 
of cotransport, and can substitute for Na+ as the cotransported cation species, however these data 
offer little insight into which of the 3 cation binding sites are involved. The altered voltage 
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dependence suggested that Li+ ions interact with one or more voltage-dependent partial reactions 
that constitute the NaPi-II transport cycle, nevertheless it is possible that electroneutral partial 
reactions may also be the target, because the overall steady-state kinetics is a function of all 
transport cycle-associated rate constants. To determine which partial reactions were involved, we 
investigated the effect of cation substitutions on presteady-state charge movements that we have 
previously shown reflect voltage dependent partial reactions of the transport cycle (4-6, 8, 10).  
 Fig. 7 shows representative original records membrane current relaxations under different 
superfusion conditions for voltage steps from a -60 mV holding potential (Vh) to test voltages in 
the range -180 mV to +80 mV. For a representative non-injected oocyte this protocol induced 
linear transient current relaxations that typically lasted 1-2 ms with low-pass filtering at 500Hz 
(Fig. 7A).  For a flNaPi-IIb-expressing oocyte from the same donor frog and superfusion in 100 
mM NaCl (100Na), 100 mM choline Cl (100Ch) and 100 mM LiCl (100Li) respectively, voltage 
steps gave rise to relaxations that were superimposed on the endogenous transients (Fig. 7B). 
The presence of relaxations for superfusion in 100Li suggested that, like Na+, Li+ ions were able 
to interact with the expressed protein in a voltage dependent manner. We also observed 
relaxations if the oocyte was superfused in 50:50 mixtures of the superfusates (Fig. 7C). 
Remarkably, for the case of superfusion in 50%NaCl, 50%LiCl (50Na50Li), the relaxations for 
steps to potentials >0 were significantly slower than those in the absence of Li+.  
 To quantify these observations, we determined the charge (Q) associated with NaPi-IIb 
by fitting the relaxations to exponentially decaying functions (see Materials and Methods). For 
superfusion in Na+ and choline, the relaxations were well described by fitting a single 
exponential to the relaxation after the linear capacitive component was complete (see Materials 
and Methods). However, when both Li+ and Na+ were present, a double exponential fit was 
found to describe more accurately the current decay (see Materials and Methods and Fig S1, 
Supporting material). The faster time constants (Fig. 7D, left panel) were typically <10 ms over 
the test voltage range and showed a “bell-shaped” dependence on V as previously reported for 
the flNaPi-IIb (4, 6). The slow time constant observed for superfusion with 50Na50Li showed a 
strong voltage dependence but no maximum was observed for test potentials up to +80 mV (Fig 
7D, right panel). For V<-60 mV, although the fitting algorithm reported a slow component, the 
poor signal-to-noise ratio for hyperpolarizing steps meant that there was greater uncertainty in 
the fit (Fig 7D, right panel). 
 Fig 8 shows normalized Q-V data obtained from the exponential fit for each of the 
superfusion conditions. These data were fit with a single Boltzmann function (Eqn. 2, Materials 
and Methods) to obtain 3 phenomenological parameters: Qmax, the predicted maximum charge 
displaced, V0.5 the voltage at which 50% of the charge is displaced and z the effective valency 
factor (Fig. 8B-D). Given the significantly different time constant associated with the 50Na50Li 
superfusion, we took pains to ensure that this was not artifactual. To this end, we confirmed that 
the charge movement due to the presence of Li+ fulfilled 3 properties expected for a fixed 
number of mobile charges that can move within the transmembrane electric field and are directly 
associated with functionally expressed NaPi-IIb. These properties are: (i) the total charge 
displaced was proportional to the IPi (see Fig S2A, Supporting material);  (ii) the charge 
movement was reversible over the test voltage range-i.e. the magnitude of charge induced by the 
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ON step (from Vh to the test potential) and OFF step (from the test potential to Vh) were in good 
agreement (see Fig S2B, Supporting material); and (iii) the charge movement was the result of 
memoryless process: i.e. by changing Vh to +40 mV the Q-V was displaced along the Q axis (see 
Fig S2B, Supporting material) and, moreover, we obtained comparable estimates of the 
Boltzmann parameters (Qmax, V0.5, z).  
To compare the effects of cation substitution in more detail, we normalized the Q-V data 
to Qmax in 100Na and offset each set to superimpose at the depolarizing limit (Fig. 8A). The total 
detectable mobile charge approximately doubled when Na+ (50 mM or 100 mM) alone was 
added to the medium compared to the 100Ch case (Fig. 8B) and doubling [Na+] caused a 
depolarizing shift for V0.5 of ~25 mV (Fig. 8C), consistent with previous reports (6, 28). 
However, replacement of 50% of Na+ with Li+ caused a further depolarizing shift of ~50 mV 
relative to the 100Na case (Fig. 8C). This finding provided further support for the notion that Li+ 
ions interacted with the NaPi-IIb protein and altered the voltage dependent kinetics. Moreover, 
although we were unable to apply voltage steps beyond +80 mV because of contamination of the 
records from the activation of endogenous Cl- channels, the Qmax prediction from the Boltzmann 
fits strongly suggested that this parameter remained reasonably constant for the 3 conditions: 
100Na, 50Na50Ch and 50Na50Li (Fig. 8B). Finally, the apparent valency (z) increased above 
that of the empty carrier value (0.40±0.04) when Na+, Li+ or both Na+ and Li+ were present in the 
superfusate (Fig. 8D). With only Li+ present, the valence increased to 0.52±0.04, whereas when 
Na+ it varied from 0.56±0.02 (50Na50Ch) to to 0.65± 0.02  (100Na). 
Qualitatively similar behavior was observed for the human and rat NaPi-IIa isoforms 
(data not shown), which confirmed that the effect of Li+ on the voltage dependence of presteady-
state kinetics was not unique to the WT NaPi-IIb. Moreover, the generality of the effect was 
demonstrated using a mutant NaPi-IIb isoform (A175C) that shows a significantly different 
voltage dependence from the WT (14). In 100Na, its presteady-state voltage dependence is 
shifted towards hyperpolarizing potentials compared to the WT, however, in 50Na50Li, we 
observed a ~50 mV depolarizing shift in V0.5 relative to the estimate in 100Na as for the WT (see 
Fig. S3, Supporting Material). These findings indicated that independent of the intrinsic voltage 
dependence of the NaPi-II protein, the effect of Li+ ions was the same and supported the notion 
that like Na+ ions, Li+ ions bind to one or more sites located within the transmembrane electric 
field (8). When Li+ was the only alkali metal cation present in the superfusate, the total 
detectable mobile charge increased over that for 100Ch (Fig. 8B). Moreover, there was a 
concentration dependent shift in the charge distribution, qualitatively similar to Na+ (Fig. 8A, 
right panel). However, a doubling of [Li+] resulted in a smaller depolarizing shift in V0.5 (~15 
mV) compared to the Na+ case. Moreover, Qmax was approximately 70% of that obtained with 
100Na (Fig. 8B).  
We also investigated if other monovalent cations could also induce similar effects, we 
made 100% substitutions with Rb+, Cs+ and K+, however no additional charge movement was 
observed (see Fig. S4, Supporting material). This suggested that the size of the cation was of 
critical importance for interactions with NaPi-IIb as Na+ and Li+ have comparable but smaller 
atomic radii compared with the other cations investigated (e.g. (15))  
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To gain further insight into the Li+ interactions, we performed a detailed analysis of the 
presteady-state charge movements with varying [Li+] in the presence and absence of fixed [Na+] 
and the converse. Fig. 9 shows the variation of Boltzmann parameters for varying cation 
concentrations with equimolar choline substitution. For Qmax (Fig. 9A), all fit estimates were 
normalized to the predicted Qmax at 100Na for each cell and then pooled (Fig. 9A). This fit 
parameter remained reasonably constant for [Na+] or [Li+]> 10 mM and the maximum 
displaceable charge in the presence of Li+ remained at approximately 70% of that obtained in 
Na+. Both z (Fig. 9B) and V0.5 (Fig. 9C) increased with cation concentration. Whereas z was 
similar for each cation, we observed a significant difference between the respective dose-
dependent behavior of V0.5. This became more evident when these data were replotted on a 
log10[X!scale, where X= Na+ or Li+ (Fig. 9D). At high cation concentrations, V0.5 then varied 
linearly and the limiting slopes were 118± 8mV/decade and 64±3 mV/decade for Na+ and Li+, 
respectively. For [Li+] <25 mM, V0.5 deviated from the linear behavior and showed less 
dependence on [Li+]. 
In the final series of experiments, we repeated these measurements and varied one cation 
in the presence of a constant concentration (10mM and 50 mM) of the other (Fig. 10). For 
variable [Na+], Qmax , normalized to the value estimated for each cell at 100Na, was close to 
unity for [Li+]= 10 mM and 50 mM (Fig. 10A, left panel), whereas for variable [Li+] it depended 
on [Na+]. We could attribute the large error in normalized Qmax for [Na+]=50 mM and variable 
[Li+] to the lack of saturation of the Q-V at depolarizing potentials for this condition (see Fig. 
8A). This also had consequences for the uncertainty in predictions for z and V0.5. By constraining 
the fits with a fixed Qmax obtained from 100Na fit, the Boltzmann fits to the Q-V data for the 
variable [Na+] case were not compromised and the respective uncertainties in z and V0.5 were 
reduced. The effective valence (z) for both variable [Na+] and [Li+] (Fig. 10B) showed a small 
concentration-dependent increase. Moreover, V0.5 for all conditions showed a characteristic linear 
dependence on log10 [Na+] or log10 [Li+]. For variable [Na+], the limiting slopes  in the presence 
of external Li+ were significantly smaller (56 ±4 mV/decade -10 mM Li+) and 58± 6 m /decade-
50 mM Li+) compared with the slope in the absence of external Li+ (118±8 mV/decade). 
Moreover, the intercept on the [Na+] axis shifted to the left as [Li+] increased. In contrast, the 
addition of a fixed [Na+] to the external medium with [Li+] variable (Fig. 10C, right panel) the 
slopes were 64±3 mV/decade (0 mM Na+); 79±3 mV/decade (10 mM Na+) and 61±3 mV/decade 
(50 mM Na+). For this experimental protocol, the intercept on the [Li+] axis also shifted to the 
left as [Na+] increased. This apparent reciprocity of the influence of one cation species on the 
voltage dependence of the other cation suggested a reciprocal interaction between Na+ and Li+ 
ions competing for occupancy of the same site(s) in the protein. 
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Discussion 
 
Does Li+ alone act as a driving cation? 
Uptake assays in which we replaced external Na+ with Li+ suggested that Li+ may also 
drive Pi cotransport, albeit at a significantly lower turnover rate than for Na+ (Fig.1A). The low 
uptake activity precluded a more detailed kinetic analysis to determine if this resulted from a 
reduced maximum transport rate, reduced substrate apparent affinity (Li+ or Pi) or combination 
of both. Based on the uptake data, we would predict that voltage clamped oocytes expressing 
flNaPi-IIb with typical Pi-induced currents (IPi) > -200 nA at -100mV (1 mM Pi) would therefore 
give correspondingly small IPi ≈ -6 nA in 100 mM Li
+
. By means of electrophysiological assays, 
we were unable to detect a significant inward current in the presence of 100 mM Li+. Although 
currents in the nA range are certainly detectable with the TEVC, we routinely observed that non-
injected oocytes could also display an electrogenic response to Pi within this range. This is 
thought to be related to endogenous chloride channels (I:C: Forster, unpublished observations) 
and could easily mask any NaPi-IIb dependent Pi response in 100 mM Li+. Based on the 
uncertainties in resolving such small currents, we were unable to conclude definitively that Li 
alone can induce an electrogenic response from NaPi-IIb. We also obtained evidence that Li+ 
ions alone can specifically interact with NaPi-IIb from the presteady-state assays in this present 
study (see below) as well as from voltage clamp fluorometry studies on both NaPi-IIb (28, 29) as 
well as the electroneutral NaPi-IIc (13).  
It could also be hypothesized that the 32P uptake measured in 100 mM Li+ was the result 
of transport via endogenously expressed proteins from the SLC20 family (e.g. PiT-1,2), given 
that in oocytes overexpressing the Xenopus PiT-1 a resolvable electrogenic response was found 
in 100 mM Li+ (25). In the present study, there was indeed  a significantly higher uptake in 
100Li compared with 100Ch for non-injected oocytes, which could suggest the involvement of 
endogenous PiT, however the overall levels were 10-fold lower than in oocytes expressing NaPi-
IIb. Given the significance of the uptake data with 100 mM Li+, we therefore conclude that Li+ 
ions can fully substitute for Na+. A clearer role for Li+ as a driving cation was obtained in assays 
performed in the presence of Na+.  
 
 Steady-state kinetics reveal complex interactions of Li+ in the presence of Na+. 
 Our uptake assays in which 50% of the external Na+ was equimolarly replaced with Li+ 
gave the first hint of a direct influence of Li+ ions on the cotransport cycle and suggested that 
when Li+ was present, transport was inhibited (Fig 1 B). We obtained further insight into this 
phenomenon from electrophysiological assays. A comparison of the current-voltage (I-V) data 
(IP) when choline or Li+ replaced Na+ and the total cation concentration remained constant (Fig. 
2A), confirmed the apparent inhibitory effect of Li seen in the uptake experiments. We also 
observed a clear alteration in the steady-state voltage dependence, whereby the normal rate-
limiting, voltage-independent behavior observed at hyperpolarized potentials occurred at less 
negative potentials as [Li+] increased. This was accompanied by a concomitant decrease in the 
electrogenic response. These altered steady-state kinetics suggested that Li+ ions could influence 
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one or more partial reactions in the transport cycle that determine the overall voltage dependence 
of transport as well as the turnover rate (cotransport rate) of the protein.  
 An additional indication that membrane potential-dependent partial reactions should be 
considered in explaining the uptake data (Fig 1B) came from a recent study on the electroneutral 
isoform, NaPi-IIc (13). This protein shows no steady-state or presteady-state charge movement, 
and 32P uptake is voltage-independent, which led us to conclude that no voltage-dependent 
partial reactions contribute to the transport cycle. Furthermore, it was reported that there was no 
significant change in uptake when 50% of Na+ was replaced with Li+ (13). This finding could 
suggest that the Li+ effects reported in the present study were unique to the electrogenic NaPi-
IIa/b and implied an interaction of Li+ ions with voltage-dependent partial reactions only. 
 When choline progressively replaced Na+, the electrogenic response tended to saturate at 
high [Na+] as previously reported (e.g. (4, 6, 26)). In contrast, Li+ replacement revealed a more 
complex behavior, as might be expected for an interaction between different cations at 
intermediate concentrations (Fig. 2B,C). Surprisingly, although Li+ reduced the electrogenic 
activity, it increased the apparent affinity for Pi (Fig 3B). This behavior would not be expected 
for a simple competitive inhibition of transport by Li+, for which we would expect a decrease in 
the apparent affinity for Pi and an unchanged maximum transport rate.  
 It was previously reported for the Na+-coupled succinate transport (NADC-1) (23) that 
Li+ ions, in the presence Na+ ions, caused a mixed type inhibition to account for the reduced 
apparent succinate affinity and reduced maximum transport rate for that transporter. Moreover, 
the effects of Li+ on NaDC-1 were observed at relatively low [Li+] (5 mM). For NaPi-IIb, our 
steady-state data also suggest a complex Li+ interaction. For the Na+-activation experiments with 
fixed [Pi], the apparent affinity for Na+ increased in the presence of 50 mM Li compared with 
choline substitution (Fig 4D).  Moreover, these experiments revealed that the normally sigmoidal 
behavior observed for Na+-activation with choline replacement was best described by a 
Michaelian function. This suggested that if Li+ ions modulated the transport cycle, but did not 
participate as a driving cation, their presence significantly reduced the cooperativity of Na+ 
interactions. Alternatively, we could explain this behavior if Li+ ions replaced one or more Na+ 
ions in the transport cycle. 
 When we maintained a constant [Na+] = 50 mM and determined the Li+-activation with 1 
mM Pi, (Fig 5B) we also found that the Li-dependence could best be described by a Michaelian 
function, which suggest that one Li+ ion interacted with the protein. Moreover, these data 
provide further confirmation that Li+ does not act as a simple competitive inhibitor of Pi transport 
because as [Li+] increased, the transport rate reached a plateau that was weakly voltage 
dependent. We might expect this behavior if two cotransport pathways were possible: one 
involving Na+ ions alone with a high transport turnover rate and another in which both Li+ and 
Na+ ions participated and with a lower turnover rate. We would then predict that the latter 
pathway would progressively dominate as [Li+] increased until a limiting transport rate was 
reached. Interestingly, the normalized I-V data reported in Fig 5A for each [Li+] were the same at 
V= 0 mV. This indicated that in the absence of membrane potential as a driving force, 
cotransport activity was unaffected by the presence of external Li+. Moreover, Michaelian 
behavior for Li+ interaction was consistent with voltage clamp fluorometry (VCF) data obtained 
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from the same isoform (29), which indicated that one Li+ ion interacted with the protein in the 
absence of Pi. For NaDC-1, similar behavior was reported whereby the inhibition by Li+ was best 
described by a Michaelian function and the maximal inhibition ranged from 54% at -150 mV and 
76% at -10 mV (22). 
 
Stoichiometry determination establishes that Li+ can substitute for Na+ in the transport cycle. 
The correlation between charge translocated (Qt) and Na+ uptake under voltage clamp 
conditions provided strong experimental evidence that Li+ ions can substitute for Na+ as a 
driving cation. Although there was some experimental scatter in the data, equimolar Li+ 
substitution for choline resulted in a statistically significant reduction in the stoichiometry ratio, 
which would be expected if Li+ substituted for one or more Na+ ions in the transport cycle. It is 
tempting to conclude from these data that in the presence of Li+, the ratio nNa:nQt = 2 implying 
that one Li+ ion has substituted for one of the 3 Na+ ions cotransported. However, uncertainties 
in the data do not allow us to rule out that >1 Na+ ion is replaced by Li+. Indeed, the non-integer 
stiochiometry we observed at the macroscopic level could arise from a mixed population of 
proteins operating with nNa:nQt =3, 2 or 1, depending on the occupancy of cation binding sites on 
a cycle-to-cycle basis. 
Despite these uncertainties, these findings did allow us to rule out two hypotheses for the 
mechanism of Li+ interaction. First, if Li+ suppressed electrogenic cotransport but the protein 
completed the transport cycle in an electroneutral mode, we would expect the ratio nNa:nQt to 
increase above the 3:1 obtained for superfusion with only Na+ present. Second, if Li+ 
competitively inhibited cotransport, this would not result in a change in stoichiometry.  
 
Presteady-state analysis reveals separate cation interactions that precede Pi binding 
The above findings suggest an involvement of voltage-dependent partial reactions 
explaining the Li+ effects. However, it is difficult from steady-state data alone to make clear 
predictions as to which partial reactions are Li+-dependent because the electrogenic response is a 
function of all partial reactions in the transport cycle. To identify the partial reactions involved it 
was necessary to exploit the power of presteady-state analysis, whereby we could investigate 
cation interactions for a limited set of partial reactions in the transport cycle (see Fig 11).  
When Li+ ions alone were present in the external medium there was an increase in the 
detectable charge movement that was significantly greater than that measured in 100Ch,  which 
we attribute to voltage-dependent conformational changes associated with the empty carrier (e.g. 
(8)). These findings contrast with those of a previous study where we reported that there was 
only a marginal difference between the Qmax predicted in 100Ch and 100Li for the flNaPi-IIb 
mutant S448C (29): this led us to conclude that Li+ ions did not enter the transmembrane electric 
field. In the present study, we found a ∼50% increase in total mobile charge movement (Qmax) 
compared to that of the empty carrier (100Ch). This discrepancy might be attributable to the 
effect of the cysteine mutation on cation interactions or that in the present study we chose high 
expressing cells with an electrogenic response < -400 nA (1 mM Pi) , which facilitated more 
precise estimation of charge movement.  
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In the present study, we found that Qmax in 100Li was only ∼70% of that obtained in 
100Na. One interpretation of this finding, based on the predictions of a simple two-state model 
for charge displacement that the Boltzmann function describes (e.g.(8)) would be that in 100Li, 
the lumped mobile charges in each protein (in this case Li+ ions) move through a smaller fraction 
of the transmembrane electric field to reach their binding site compared with the 100Na case. 
This is also consistent with the Boltzmann fit estimate of the apparent valence (z) for 100Li 
being less than that found for 100Na or 50Na50Ch (Fig 8D) and the finding that the apparent 
valence is smaller in 100 mM Li. If both Na+ and Li+ were present in the external medium 
(50Na50Li), Qmax was similar to the 100Na case, which suggested that the charge contribution 
due to the Li+ alone was not the result of Li+ interacting with the protein at an independent site. 
In that case, we would expect Qmax to exceed that for 50Na50Ch, where Qmax was close to that in 
100Na. Another explanation for our finding could be one Li+ ion can bind with high affinity to 
the 1st cation binding site leaving the 2nd cation binding site free for Na+ occupancy. 
Our initial presteady-state analysis (Fig 8) also revealed that the steady-state mobile 
charge distribution (Q-V) was significantly affected by the cation species present in the external 
medium (Fig 8A). This could be quantified in terms of the midpoint voltage (V0.5) at which 50% 
of the charge was displaced (Fig 8C). When Na+ was the only cation present, a 50% reduction in 
[Na+] resulted in a V0.5 hyperpolarizing shift ≈27 mV, whereas when Li+ was the only cation 
present the shift was in the same direction but significantly smaller (≈15 mV). However, the 
most dramatic effect was observed for 50Na50Li, which resulted in ≈ 81 mV depolarizing shift 
relative to 50Na50Ch.  
For the case with only one cation species present, the basic interpretation of these shifts 
with changes in cation activity can be obtained by considering a 2-state model in which the 
cation is either bound or unbound and it must cross an energy barrier to reach the binding site 
(see Appendix 1). This model predicts a linear relationship between V0.5 and [X] plotted 
logarithmically with slope SX= kT/(eδX) where δX is the electrical depth of the binding site 
within the transmembrane electrical field and the apparent cation affinity (Kx) can be found from 
the intercept on the log[X] axis. For Na+ or Li+ as the only cations, (Fig 9) linearity between V0.5 
and log[X] was obtained (Fig 9) for [Na+] or [Li+] ≥ 50 mM and the limiting slopes were 
significantly different. For Na+ alone, the slope is approximately 120 mV/log [Na] , consistent 
with 2 Na+ ions interacting before Pi binding (29). Using the derived expressions for the slope 
and total charge displacement (see Appendix), the ratio of limiting slopes is given by: 
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Substituting the measured slopes and QXmax, for the respective ions, we obtain the ratio 
nLi/nNa = 0.35. This indicates that the number of Li+ ions that interact with the transporter is less 
than the number of Na+ ions. Given that our current model predicts that nNa=2, this result would 
be consistent with nLi= 1. Furthermore, the intercepts on the log[Na+] and log[Li+] axes were 100 
mM and 75 mM respectively, suggesting that Li+ ions interacted with a greater affinity than Na+ 
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ions. It must be noted that this 2-state model neglects the charge contributions from the empty 
carrier, which explains the lack of linearity for V0.5 data at low [X] and the model also assumes 
that the ions bind simultaneously, which may also explain why the ratio nLi/nNa is not closer to 
the expected 0.5, suggested by our model.  
 We obtained further insight into the cation interactions by determining the Boltzmann 
parameters from the Q-V data when one cation was varied with the other fixed at 10 mM or 50 
mM (Fig. 10). These data confirmed that for variable [Na+] ≥ 10 mM, Qmax was independent of 
[Na+] and appeared to be unaffected by 10 mM or 50 mM Li , despite a large uncertainty in the 
fit parameters due to the lack of saturation at depolarizing potentials. In contrast, for variable 
[Li+], whereas Qmax was independent of [Li+] for [Li+]≥ 10 mM, but increased with [Na+] = 10 , 
50 mM, respectively. With Na+ as the variable cation, the limiting slope was ≈60 mV/log10[Na+] 
for [Li+]=10 mM and 50 mM; with Li+ as the variable cation, the limiting slope varied between 
61 mV/log10[Na+] (50 mM Na+) and 79 mV/log10[Na+] (10 mM Na+). For both sets of data, an 
increasing concentration of the fixed cation shifted the intercept on the log10[X] axis to the left. 
According to the 2-state model (see above) this indicated that the apparent affinity of the variable 
cation increased with the fixed cation concentration. The reciprocal behavior would not be 
expected if both cations competed for the same binding site, but suggests a cooperative 
interaction, whereby the binding of one cation increases the apparent affinity for the other.  
  
A revised kinetic scheme for electrogenic NaPi-II transporters 
The interpretation of the presteady-state data in terms of a 2-state model for cation 
interaction gave some insight into the complexity of the Na+ and Li+ interactions but was 
obviously of limited value considering the underlying assumptions. A more realistic, but 
algebraically complex, model for Na+ interactions has been proposed (e.g. (12)) that comprises 4 
states and two sequential partial reactions to account for the 2 Na+ ions predicted to bind before 
Pi binds ((29)). This model also takes into account the role of the empty carrier in determining 
the voltage dependent kinetics in the transport cycle, and for simplicity, assumes the 2nd Na+ 
partial reaction is electroneutral. To account for the present findings, we propose that this model 
be extended to incorporate two cotransport cycles depending on whether Li+ is present or not 
(Fig 11). We assume that Li+ can only bind at the first cation binding site, which becomes 
available when the empty carrier occupies state 1. When Li+ is bound, a 2nd Na+ ion binds 
cooperatively and cotransport proceeds such that 2 Na+ ions and 1 Li+ ion are cotransported with 
Pi. This would account for the reduced stoichiometry that we observed. The probability of this 
cycle occurring depends on the relative concentrations of Li+ and Na+ in the external medium. 
With Li+ as the only monovalent cation in the external medium, cotransport is unfavoured 
because 2 or 3 Li+ ions cannot easily bind to the transporter. This situation, not shown in the 
scheme, would account for the low uptake reported in 100Li. In the absence of external Na+ and 
Pi, we therefore predict that Li+ can preferentially only occupy the first cation binding site and 
therefore this accounts for the lower Qmax observed and reduced apparent valence compared with 
the case when Na+ is also present. This also implies that there must be some charge movement 
associated with the 2nd cation (Na+) interaction and therefore our original electroneutral kinetics 
predicted for this partial reaction (2a↔2b, Fig 11) would need to be revised accordingly. If this 
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is the case, then the presteady-state kinetics obtained in 100mM Li offer a valuable insight into 
the cation interactions with NaPi-IIa/b at the molecular level for they reflect the voltage 
dependent interactions of a single cation with the protein.  
Finally, to account for the altered voltage dependence of presteady-state Q-V when both 
Li and Na+ are present, we predict that the backward rate constant for the 2nd Na+ binding partial 
reaction (2b’→2a) will become much slower than when Na+ occupies the first cation binding 
site, thereby conferring an apparent increase in Na+ and Pi affinity. 
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Appendix 1. Two state barrier model for cation interaction 
 
We consider a simple 2-state model in which the cation is either bound (state 2) or 
unbound (state 1) and it must cross a sharp energy barrier to reach the binding site. We can apply 
Eyring transition state theory (e.g. (15)), to express the rate constants associated with the forward 
(binding) and backward (dissociation) reactions as functions of membrane potential (V). 
Assuming pseudo 1st order kinetics, the forward rate is proportional to the activity 
(concentration) of the ion (X) according to the law of mass action. The rates for a symmetrical 
barrier are then given by: 
  
          (A1a) 
 
 
          (A1b) 
where nX= number of cations of X binding simultaneously at a site located an equivalent 
electrical distance δ X through the transmembrane electric field, k012 and k021 are the  forward and 
backward rates with V=0. Then for N transporters, the total charge displaced is given by: 
 
   QXmax= N e nX δX     (Α1c)  
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where Kx is the apparent affinity constant for X (at V=0) and k, T, e have their usual meanings 
(e.g. (20)). Thus, there is a linear relationship between V0.5 and [X] plotted logarithmically with 
slope SX= kT/(eδX) and Kx can be found from the intercept on the log[X] axis.  
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Figure legends 
Figure 1. Evidence of Li+ interaction with NaPi-IIa/b from 32P assays. 
(A) For oocytes expressing flounder NaPi-IIb, replacement of Na+ with Li+ (open bars) in the 
uptake medium gave significantly greater uptake (upper panel) than for non-injected (NI) 
oocytes from the same donor animal (lower panel). Note the 10-fold difference in ordinate scales 
in the two panels. Data pooled from n=9 oocytes (2 animals). Data were normalized to the mean 
uptake in 100Na for each isoform.  
(B) Comparison of 32P uptake when 50% of Na was equimolarly replaced with choline 
(50Na50Ch, black bars) or Li+ (50Na50Li, open bars). Data pooled from n=21 oocytes from 
three donor frog. Data were normalized to mean uptake in 50Na50Ch for each isoform. 
 
Figure 2. Partial replacement of Na+ with Li+ alters the voltage dependence of phosphate 
induced current 
(A)  Normalized current-voltage (I-V) data showing the voltage dependence of phosphate 
dependent current (IPi) in response to 1 mM Pi for different cation replacements: 25%, 50%, 75% 
choline Cl (gray circles) and LiCl (open circles). The black squares represent the IPi recorded in 
100Na and the open squares the recorded IPi in 100Li. In each case the data points were 
normalized to IPi at -100 mV (100Na) in response to the superfusion of 1 mM Pi. Continuous 
lines are the result of fitting the data with a sigmoidal function to indicate voltage-independent 
rate limiting behavior at hyperpolarizing V.  Data pooled from n=7 oocytes. Typical IPi at -100 
mV in 100Na in response to 1 mM Pi was -200 nA.  
(B) Transposed I-V data showing the dependence of normalized IPi on  external  [Na+] . Data 
points are joined by straight lines for visualization. Data from n=8 oocytes normalized to the 
response at 100Na, -100 mV. 
(C) Transposed I-V data showing the dependence of normalized IPi on external [Li+]. Data points 
are joined by straight lines.  Data from n=10 oocytes normalized to the response at 100Na, -100 
mV.  
 
Figure 3. Effect of Li+ on Pi-activation 
(A) Comparison of I-V data showing variation of IPi with V for 5 concentrations Pi indicated with 
50% choline replacement (upper panel) or 50% Li+ replacement (lower panel). Data points 
normalized to IPi at -100mV in 100Na, 1 mM Pi and joined for visualization.  
(B) Transposed data from (A) fitted with Eqn 1.  
(C) I-V of predicted maximum electrogenic response to Pi (IPimax) obtained from fits in (B). Data 
points joined for visualization. 
(D) Comparison of voltage dependence of the apparent affinity constants (K0.5Pi) for each 
superfusion condition.  
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Normalised substrate activation data were pooled from n= 7 cells. Error bars in fit parameters 
represent SE reported by fitting algorithm. 
 
Figure 4. Effect of Li+ on Na-activation with 1 mM Pi 
(A) I-V showing variation of IPi with V for 6 [Na+]. Data points normalized to IPi at -100mV, 1 
mM Pi and joined for visualization. 
(B) Transposed data from (A) fitted with Eqn. 1. Data is also shown for a representative oocyte 
with choline replacement. 
(C) Comparison of Hill coefficient (nH) plotted as a function of membrane potential, or 0 mM 
Li+ and 50 mM Li+. Error bars represent SE reported by fit using Eqn. 1 to data in (B). 
(D) Comparison of apparent affinity (K0.5Na) plotted as a function of membrane potential for 0 
mM Li+ and 50 mM Li+. Error bars represent SE reported by fit using Eqn. 1 to data in (B) 
(E) Comparison of maximum Pi-induced current (IPimax) for 0 mM Li+ and 50 mM Li+. 
 
Figure 5 Li+ inhibition of Pi-activation at 50 mM Na 
(A) I-V showing dependence of IPi on V for 5 [Li+] indicated. Data points normalized to IPi at -
100mV, 1 mM Pi in 100Na (not shown) and joined for visualization. 
(B) Transposed data from (A) fitted with Eqn. 1 (nH=1) with a variable offset to take account of 
IPi with [Li
+]=0. 
(C) Comparison of apparent Michaelis constant for inhibition by Li+ (K0.5Li) plotted as a function 
of membrane potential. Error bars indicate SE reported by fit using Eqn. 1. 
 
Figure 6. Lithium alters flNaPi-IIb stoichiometry 
(A) Relationship between net charge transfer (Qt) and radiolabeled Na+ uptake for oocytes 
expressing the flounder NaPi-IIb isoform and voltage clamped at -50 mV in the presence of 40 
mM and 20 mM Na+ together with 60 mM and 80 mM choline Cl respectively. Both Qt and Na+ 
uptake were expressed as their molar equivalents (nNa+, nQt). Each point was obtained from a 
single oocyte. The respective data sets were fit with a linear regression line with variable slope 
and Y-axis intercept to take account of endogenous uptake in control oocytes. Slopes shown 
were not significantly different and support nNa+:nQt stoichiometry of 3:1, as previously reported 
(9).  
(B) Relationship between Qt and radiolabeled Na+ uptake as in (A) in the presence of 40 mM and 
20 mM Na+ together with 60 mM and 80 mM LiCl respectively. Each point was obtained from a 
single oocyte. Linear regression fitting as in (A). The slopes were statistically different from 
each other (Student’s t-test p<0.03)  and indicate a reduction of stoichiometry due to the 
presence of Li+ in the medium. The gray dotted line represents the ratio equal to 3. 
 
 
 
Figure 7. Li+ substitution and presteady-state charge movement 
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(A) Voltage step protocol used for inducing presteady-state charge relaxations (left) and response 
of a representative non-injected (NI) oocyte (right). For this cell, large positive voltages also 
evoked a response from endogenous Cl- channels (red trace). The maximum and minimum of 
each capacitive charging transient have been clipped graphically.  
(B) Current traces recorded from a representative oocyte expression flNaPi-IIb (from same donor 
frog as in (A)) in response to the protocol in (A) under three superfusion conditions: 100 mM 
NaCl (100Na); 100 mM LiCl (100Li) and 100 mM choline Cl (100Ch). The red trace 
corresponds to a voltage step to +80 mV. 
(C) Current traces from the same cell as in (B) superfused as indicated. 
(D) Voltage dependence of time constants obtained from fitting the ON relaxations (steps 
fromVh= -60 mV to test potential) in (B) and (C) to single (100Na, 50Na50Ch) and double 
(50Na50Li) exponential functions. Note the different scales for the 50Na50Li data. Each data 
point is mean ±SEM for 6 cells. Data points are joined to aid visualization. 
 
Figure 8. Analysis of presteady-state charge movement for different cation substitutions. 
(A) Normalized charge-voltage (Q-V) data pooled from n= 6 oocytes for the superfusion 
conditions indicated. Continuous lines are fits using Eqn 2. Data were normalized to Qmax 
predicted from 100Na fit. All data sets were adjusted so that they were superimposed at the 
depolarizing limit predicted by the fit. 
(B) Comparison of normalized maximum charge movement (Qmax) for each superfusate. Dashed 
line indicates reference value (100Na).  
(C) Comparison of midpoint voltage (V0.5) for each superfusate.  
(D) Comparison of apparent valence (z) for each superfusate. Dashed line indicates mean z 
estimated for empty carrier (100Ch).  
In B-D, Bars indicate mean±SEM reported by fit to pooled data (n= 9). 
 
 
Figure 9. Boltzmann parameters reported by fits to Q-V data with varying [Li+] or [Na+] 
with equimolar choline. 
(A) Pooled Qmax data plotted as a function of [Na+] (filled symbols) or [Li+] (open symbols). 
normalized to Qmax estimated for each cell in 100Na and 0 mM Li. Dotted line indicates 
normalization level. Each point is mean±SEM for n>6 cells. Data points joined for visualization. 
(B) Pooled effective valence (z) for same cells as in (A) plotted as a function of [Na+] (filled 
symbols) or [Li+] (open symbols). Data points joined for visualization. 
(C) Pooled midpoint potential (V0.5) for same cells as in (A) plotted as a function of [Na+] (filled 
symbols) or [Li+] (open symbols). Data points joined for visualization. 
(D) Data in (C ) replotted on a log10[Na+] or log10[Li+] scale. Linear regression lines are plotted 
on points that showed an obvious linear relationship. Note the strong deviation from linearity for 
the Li+ data at low [Li+]. 
 
Figure 10. Boltzmann parameters reported by fits to Q-V data for varying [Li+] or [Na+] in 
the presence of fixed concentrations of the other cation 
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(A) Pooled Qmax data plotted as a function of [Na+] (left panel) or [Li+] (right panel). normalized 
to Qmax estimated for each cell in 100Na+ and 0 mM Li+. In each case, the constant cation 
concentration is indicated. Dotted lines indicate normalization level. Each point is mean±sem for 
n>4 cells. Data points joined for visualization. 
(B) Pooled effective valence (z) for same cells as in (A) plotted as a function of [Na+] (left panel) 
or [Li+] (right panel). In each case, the constant cation concentration is indicated. Data points 
joined for visualization. 
(C) Pooled midpoint potential (V0.5) for same cells as in (A) plotted as a function of log10[Na+] 
(left panel) or log10[Li+] (right panel). Each point is mean±SEM for n>4 cells. Data points joined 
for visualization. Linear regression lines are plotted on points that showed an obvious linear 
relationship. In each case, the constant cation concentration is indicated. 
In each plot, the data points from Fig 9 corresponding to 0 mM Li+ or Na+ have been replotted to 
aid comparison 
 
Figure S1. Comparison of exponential fits to presteady-state relaxations recorded in 
50Na50Li.  
Presteady-state relaxations for voltage steps indicated and superfusion in 50Na50Li were fit with 
a single exponential decay (left panel) or 2 exponential decay (right panel). The residuals show 
difference between original data trace and respective fits. 
 
 
Figure S2. Characteristics of charge displacement associated with NaPi-IIb expression.  
(A) Total displaceable charge (Qmax), detected in 100Na, 50Na50Ch and 50Na50Li, is 
proportional to IPi at -100 mV. Each point was obtained from a single oocyte.  Linear regression 
lines indicate that the slopes are significantly different for each superfusion condition 
(B) Q-V for ON (from holding potential, Vh = -60 mV, +40 mV) to test potential (V) and OFF 
(from V to Vh) obtained from the same oocyte superfused with 100Na (left panel) and 50Na50Li 
(right panel). 
 
Figure S3. Li substitution and presteady-state behavior of mutant A175C 
(A) Pooled Q-V data for mutant A175C (n = 5) normalized to predicted Qmax for 100Na 
superfusion. Continuous lines are fits with Eqn. 2 with Qmax constrained to 1. Data points were 
shifted so that all fits superimposed at the depolarizing limit. 
(B) Apparent valence (z) for 3 superfusion conditions indicated. Bars indicate mean±sem 
reported by fit to pooled data. 
(C) Midpoint voltage (V0.5) reported from Boltzmann fits for 3 superfusion conditions indicated. 
Bars indicate mean±SEM reported by fit to pooled data. 
 
 
 
Figure S4. Substitution of Rb, Cs or K does not evoke additional charge movement. 
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Normalized Q-V data pooled from n= 5 oocytes for superfusion with 100% replacement (100 
mM) of Na with choline, Rb+, Cs+, Li+ and K+. Continuous lines show Boltzmann fits (Eqn. 2). 
Only Li+ showed a significantly increased detectable charge movement compared with 100Ch. 
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3.2 Unpublished material: 
 
3.2.1 Cut-open voltage clamp technique (COVC): access to the cytoplasmic side of 
the membrane. 
Introduction 
 As already mentioned in the previous sections, some cotransporters are electrogenic and 
they have been characterized by Two-Electrode Voltage Clamp technique (TEVC). This 
technique has three main shortcomings:  
(i) lack of easy access to the cytoplasmic site of the membrane; 
(ii) relative “slow” clamping speed, whereby the membrane potential cannot settle faster 
than a several hundred µs. Therefore, the resolution of currents with fast kinetics is 
limited; 
(iii) relative slow extracellular perfusion systems due to the oocyte dimension (i.e. large 
sphere). 
In the following section, I will give few examples of how it is possible to overcome these 
shortcomings and explain principles of Cut-Open Voltage Clamp as well as technical details 
about this system. 
To overcome the inaccessibility to the cytoplasmic side of the membrane some indirect 
methods such as dialysis and injection of solutions are available (12, 90): 
- dialysis procedures typically involve overnight incubation of oocytes in a specific 
medium (e.g. Na+-free solution) to allow the cells to equilibrate and thereby eliminate 
or reduce a specific ion present inside the oocyte; 
- microinjection allows studies on transport activity by cytoplasmic microinjection of a 
solution containing co-substrates/substrates/inhibitors (solutes).  
Neither dialysis nor microinjection is suitable to investigate transporter kinetics, because 
the control of internal solute concentration is not precise. Moreover, microinjection of solutes 
during an experiment may result in significant mechano-electrical artifacts due to the damage of 
the oocyte membrane around the microinjection pipette and movement of the cell, especially if 
large volumes are injected.  
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None of these methods eliminates the other two shortcomings present in the TEVC, 
namely the slow clamp performance and speed of external solution exchange.  
 A more precise control of the solution exchange can be performed by using sophisticated 
electrophysiological techniques such as the patch-clamp method and the giant-excised 
membrane-patch method, where a small part of the membrane, or the entire cell, can be voltage 
clamped by a single glass micropipette (see Table 3.1). These two methods allow the 
accessibility to the internal and external media, moreover, the clamped surface is small (3-1200 
µm2) leading to an increased clamp speed performance. 
 The standard patch-clamp method uses patch-clamp pipette tips that are normally 0.5-2 
µm diameter. This gives the possibility to have a fast clamp due to the small size of the clamped 
area (1-3 µm2). Of particular interest is the inside-out configuration that gives direct access to the 
cytoplasmic side of the membrane. Three main problems must be addressed when this method is 
used to study transporters: 
• magnitude of current (considering the clamped area and the transporter turnover rate, 1- 
10.000 cycles/sec); 
• stability of the preparation (less than 1 h); 
• difficult access to the extracellular medium (in inside-out configuration). 
Using this method, the transport-associated current signal cannot be readily resolved. For 
example, assuming a typical turnover rate of 100 cycle s-1 and a transporter density in the patch 
of about ~300 particles/µm2, the expected current signal would be ~320 fA (calculated from data 
reported in (62)). Moreover, in the excised patch the current signals can be difficult to measure 
due patch quality. Indeed a low quality seal might result in leak currents around the seal that will 
excess the detected signals (133).  
 The conventional configurations of the patch-clamp (i.e. whole-cell, outside-out and 
inside-out) were modified to compensate for some of the limitations (i.e. membrane patch-area 
and washout of cytoplasmic components). One method to overcome the washout of cytoplasmic 
component is the perforated-patch where the pipette solution contains a substance (e.g nystatin 
(75), anphotericin B (128)) that forms a patch with a higher resistance access in comparison to 
the whole-cell configuration. With the perforated-patch, the intracellular solute concentrations 
are preserved intact but the clamped membrane is the same as in whole-cell configuration.  
The necessity to exchange the solution in the internal pipette during a whole-cell or 
inside-out configurations was overcome by the insertion of a capillary tube (polyethylene or 
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quartz) in the internal pipette to change the solution within seconds or minutes (e.g. study of the 
regulation of potassium channels by acetylcholine (143)). A planar patch-clamp chip (Nanion 
Technologies, Germany) is now available offering an internal perfusion system in which up to 
eight intracellular solutions can be used (web reference: http://www.nanion.de/products/port-a-
patch/port-a-patch-add-ons/internal-perfusion.html). 
Another alternative to the standard patch-clamp method is the giant-excised membrane-
patch method (inside-out configuration). This method uses a large pipette tip with an inner 
diameter of 12-40 µm (corresponding to a capacitance of ~4-15 pF) giving rise to approximately 
100-fold increase in the membrane area of the patch and an additional increase in current signal 
size (133). This technique is useful to study exchangers and cotransporters in native tissue, as 
well as in expression systems like X. laevis oocytes (e.g. GAT1 (104)). Nevertheless, this 
technique also has some limitations (69): 
• seal formation requires the presence of divalent cations and chloride; 
• the seal quality has to be monitored during the experiment;  
• repeatable and stable outside-out patches are sometimes difficult to obtain 
depending on the cell type used; 
Despite the necessity to perform a seal on one side of the membrane, researchers have 
established a method that allows solutions changing via the pipette. This method is called 
“positive-pressure method” and consists of a flexible quartz tubing connected to a reservoir that 
is then connected to an air pressure system to allow solution exchanges (69).  
Technique Clamp 
speed 
Clamped 
membrane area 
Perfusion exchange Signal size 
Internal External 
Standard patch-
clamp 
5-10 µs 1-3 µm2 Inside-out 
configuration: 
internal  
Outside-out, whole 
cell configuration: 
external (133) 
~320 fA 
Giant 
membrane 
patches 
1µs 100-1200 µm2 Both possible with the positive pressure 
method (69) 
~600 fA - 
~11 pA 
Cut-Open 
(COVC) 
20/40 µs > 0.2 mm2 Both possible at the same time (145) > 19 pA 
Two-Electrode 
(TEVC) 
200 µs ~3 mm2  Only extracellular 
superfusion 
~50 nA – 
~1000 nA 
 
Table 3.1 Summary of the electrophysiological techniques applied to X. laevis oocytes and their main features. 
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Principle and development of COVC 
An alternative technique to study channels and transporters expressed in X. laevis oocytes 
is the Cut-Open Voltage Clamp (COVC) technique.  
The original design, named Cut-Open Vaseline-Gap voltage clamp (COVG), was 
developed by Stefani and Bezanilla (16, 145), the system has been further refined by others (31, 
35, 85, 149). The technique was originally developed to study potassium channels expressed in 
X. laevis oocytes in order to investigate their fast gating currents.  
In the COVC technique, a small part of the oocyte membrane is electrically isolated and 
voltage clamped. This arrangement gives (i) a good compromise between clamp speed and size 
of the clamped area and (ii) access to the internal medium. In the following sections the original 
method, as well as the major improvements to the technique, are described (see Table 3.2).  
The COVC (29, 35, 149) requires the establishment of three electrical isolated 
compartments that allow access to three different regions of the oocyte membrane (Fig. 3.1): (i) 
the top pool: gives access to the recorded membrane area; (ii) the guard pool: give access to the 
middle part of the oocyte; (iii) the bottom pool: provides electrical access to the interior of the 
oocyte.  
 
 
Figure 3.1 Schematic of the Cut-Open Voltage-Clamp chamber with simplified electronic components.  
A1, A2, A3: amplifiers, P1, P2, V2, GS1, GS2, I: electrodes. Im: output current. Vcmd: command potential.  
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The three voltage clamps that constitute the COVC system (controlled by three 
amplifiers, A1, A2 and A3) work together to (i) define the potential (V1) at the cytoplasmic side of 
the oocyte membrane to be at signal ground (= 0 mV) and (ii) clamp the top and guard pools to a 
command potential (Vcmd) defined by the experimenter. Note that this arrangement is the 
opposite of the conventional TEVC where the external potential is fixed at 0 mV and the oocyte 
interior is controlled by the voltage clamp. For the COVC, if V2 > 0 mV, the transmembrane 
potential, Vm (= V1-V2), will be negative according to the set-up currently used in our laboratory. 
The middle chamber acts as an external guard to prevent leak currents flowing between the top 
and middle pool around the oocyte membrane.  
The fast clamp performance (~20 µs) typical for the COVC is a result of the smaller 
clamped membrane area (> 0.2 mm2, 10% of the total surface of a typical oocyte) compared with 
TEVC. For COVC, this corresponds to a membrane capacitance of approximately ~25 nF. In 
addition, the internal electrode must be close to the cytosolic side of the membrane. 
The physical breaking of the oocyte membrane facing the bottom pool provides access to 
the cytoplasmic side of the upper part of the oocyte membrane. In the original technique, the 
electrical access to the cytosol was obtained by using either forceps or the detergent saponin. In 
the current set-up we penetrate the lower part of the membrane with a glass micro-capillary (OD 
1 mm, ID 0.58 mm, with a tip of 100 µm) that passes through a 1 mm hole drilled in the bottom 
chamber. 
Three electrodes are placed in the top pool: P1 and P2 comprise agar bridges (3% agar in 3 
M KCl) in contact with chlorinated silver wire electrodes via  3 M KCl solution in order to 
eliminate junction potential (Fig. 3.1). Together with amplifier A2, P1 and P2 are used to define 
the potential of the upper pool at the Vcmd. The output of A2 is a voltage proportional to the 
current passing through the exposed membrane (Im). The third electrode (V2), placed in the top 
pool, is a glass capillary (resistance 0.1 MΩ) containing 3 M KCl and silver/silver chloride pellet 
connected to the V2 head-stage via a commercial holder. This electrode senses the potential close 
to the external side of the cell membrane.  
Two electrodes are inserted in the guard pool: GS1 and GS2. Each of them comprises an 
agar bridge (3% agar in 3 M KCl) in contact with a chlorinated silver wire electrode via 3 M KCl 
solution. Together with amplifier A3, GS1 and GS2 are used to clamp the middle part of the 
oocyte membrane at the same potential as the top pool (Vcmd, Fig. 3.1).  
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The potential immediately under the oocyte upper membrane is sensed by electrode V1 
connected via 3 M KCl solution and a plexiglas support to an agar bridge (Fig. 3.1 lower inset). 
The agar bridge is attached to the internal perfusion capillary holder and a Ag/AgCl pellet 
electrode makes electrical contact with the intracellular solution via the bridge (Fig. 3.1). 
Amplifier A1, electrode V1 and an Ag/AgCl pellet electrode (I) in the lower pool are used to 
clamp the inside of the oocyte to zero (virtual ground).  
 
Cut-Open Vaseline-Gap voltage-clamp: original design 
 
The original COVC system (Bezenilla-Stefani (16, 145, 149)) was called Cut-Open 
Vaseline-Gap voltage clamp technique because vaseline rims were used to isolate the clamped 
portion (top pool) and the cut membrane portion (bottom pool) from the rest of the oocyte. The 
original idea to use the vaseline gap method was taken from the vaseline gap clamped method to 
study skeletal muscle fibers (72). The adaptation of this method to oocytes led to the Bezanilla-
Stefani set-up shown in Fig. 3.2.  
 
Figure 3.2 Schematization of the original Cut-Open Vaseline-Gap system. 
From (149). 
In this system two vaseline rims were formed manually, one rim (~300 µm) surrounded 
the guard chamber hole (guard shield, GS in Fig. 3.2) to isolate the part of the oocyte that is 
exposed to the bottom pool (I in Fig. 3.2); a second vaseline rim (~50 µm) surrounded the top 
pool hole and was critical for the quality of the recording (frequency response of the clamp) by 
preventing the recording of currents arising from the membrane under the seal (portion exposed 
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to the middle pool, GS). In the Bezanilla-Stefani design the oocyte was held in position by 
applying a positive hydrostatic pressure on top of the oocyte; the positioning of the upper part 
(A) was done manually on top of the oocyte to create the three electrical isolated pools. The 
access to the cytoplasm in the bottom pool was obtained by adding saponin (0.1%) for 1 min or 
cutting a small part of the oocyte membrane with scissors before the oocyte mounting as noted 
above (Fig. 3.2).  
Intracellular perfusion was achieved by introducing a perfusion canula (200 µm made of 
polyethylene tube) connected to a syringe perfusion system operating at a rate of 1-50 µl/h to 
provide internal solution exchange in ~5 min.  
Several modifications to this original design were accomplished to allow faster oocyte 
mounting as well as easier intracellular oocyte perfusion (Table 3.2).  
Major implementations of the original design, described in Costa et al. (Dani system 
design, (35)), concerned (i) modifications in the recording chamber and (ii) the perfusion system.  
A special feature of Dani design was the enlargement of the top pool to have more space 
for an external superfusion and a suction systems. The second improvement made in Dani 
system concerned the formation of the seal between the top pool hole and the oocyte. In their 
design, an “elevator” wheel raised and lowered the middle chamber, which led to more 
reproducible and higher resistance sealing at the access holes (Fig. 3.3).  
The internal perfusion system was improved by merging two functions: (i) control of 
intracellular medium and (ii) voltage sensing. A micropipette made from borosilicate glass (100 
µm diameter) allowed the exchange of internal medium and was positioned in a commercial 
pipette holder. In addition, an Ag/AgCl electrode (connected to V1) was screwed at the side of 
this holder to allow sensing of the intracellular voltage. This arrangement minimized the risk of 
puncturing the oocyte membrane because independent adjustment of the electrode position could 
be made. Therefore it was possible to perform long experiments (i.e. > 1h) (35). The 
extracellular perfusion system was improved by using multiple tubing connected to gravity feed 
syringes (109).  
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Figure 3.3 Chamber system adapted from the original COVG design. 
Modified from (35). 
 
Further modifications were reported from Lapointe system design to improve the 
intracellular perfusion system by changing the perfusion rate using hydrostatic pressure (70 cm 
H2O and hydraulic resistance) (31). Two more improvements were then developed and merged 
in the Schild system design (85): first, the dead space in the internal perfusion system was 
reduced by using quartz microfilaments (MicroFil, MF-34G, World Precision Instruments, 
Sarasota, FL, USA); second, the top pool was made smaller and more mobile (movement 
controlled by micromanipulator) compared to previous designs (e.g. Horisberger system, (1)). 
In our laboratory, some features of previous designs were retained (see next section).  
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System Modifications for  the 
original design 
Advantage Disadvantage 
Stefani-
Bezanilla 
(1992, (16, 
149)) 
small removable top 
chamber. 
- low signal to noise ratio (1 
nA at 3 kHz);  
- fast time resolution (20-100 
µs); (iv) stable recording (> 
1h). 
- fast external perfusion not 
available; 
- reproducibility of vaseline 
ring. 
  
Dani 
(1994, (35)) 
- larger and fixed top pool;  
- elevator wheel; 
- internal micropipette. 
- fast extracellular perfusion 
system;  
- double function of internal 
micropipette (change of 
internal solution and control of 
voltage). 
mobile middle pool. 
Lapointe 
(1995, (31)) 
- low resistance glass 
internal pipette; 
- fast internal perfusion 
rate with a drain system. 
very fast exchange in the 
intracellular solution. 
 
 
moveable middle pool. 
Horisberger 
(1999, (1)) 
- upper hole 500 µm in 
direct contact with the 
oocyte; 
- reduction of the dead 
space at 5 µm. 
reduction in the dead space for 
the internal perfusion system. 
 
Schild (2005, 
(85)) 
- moveable top chamber; 
- micromanipulator to 
control the internal pipette; 
precise alignment of holes.  relatively long set up time. 
 
Table 3.2 Summary of the modifications introduced to the original COVG design. 
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COVC: current design 
 
The COVC in our lab is to a large extent based on the Schild system developed at 
University of Lausanne (85). We used the original oocyte voltage commercial clamp, model CA-
1B, Dagan Corporation, USA. Data acquisition was performed using Digidata 1322A system 
with the pCLAMP 8.0 software package (Axon Instruments, Foster City, CA, USA). 
The realization of the top chamber 
 
The top chamber (Fig. 3.4) was redesigned in order to have:  
(i) a small volume to allow fast extracellular solution exchange; 
(ii) easy positioning of the chamber that allows more flexibility in aligning the top 
pool with respect to the oocyte; 
(iii) top pool hole manufactured with precision machining.  
The slots in the circumference of the chamber were made to hold the plastic tubes for 
perfusion as well as agar bridges for the electrodes (red arrows in Fig. 3.4). The suction needle is 
mounted on the top pool plexiglas stage (see later for details). This arrangement gave good 
mechanical stability of the top pool assembly and allowed a clear field of view of the top hole 
during mounting of the oocyte. 
 
Figure 3.4 Top chamber. 
CAD rendering of the new design of the top chamber. The ellipse shaped pool allows a fast exchange of solutions 
due to the small volume in contact with the oocyte. The slots for extracellular perfusion and for the two electrodes 
(P1 and P2) necessary to clamp the top pool are indicated. A diagonal hole (electrode GS2, arrow) was drilled in the 
top chamber to allow the close proximity of the guard electrode to the oocyte in the guard pool (courtesy of Institute 
of Physic workshop, University of Zurich). 
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For ease the manipulation, the top pool was connected via a plexiglas support to a 
micromanipulator (Three Axes, Narishige, Japan). This allows fine control of the positioning of 
the hole with respect to the oocyte membrane and a reliable high resistance seal between the 
edge of the hole and the oocyte surface (Fig. 3.5). 
The control of the top pool volume was achieved by a suction needle (24G, 90mm long 
needle, from Pajunk) attached to the top pool plexiglas support. To have the maximal flexibility, 
a micromanipulator (MS125-X, Newport) was attached to the plexiglas support. The introduction 
of this fine control (with a sensitivity of 0.5 µm and a maximum stage travel of 3.2 mm) gives 
the possibility of adjusting the volume in the top chamber also during the experiment (Fig. 3.5).  
 
 
     Figure 3.5 Photo showing the top part of the chamber. 
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Other improvements  
 
As in the Schild design of the chamber system (85), the guard chamber was positioned 
within the bottom chamber and the alignment between the bottom hole (1 mm) and the guard 
funnel-shaped hole (bottom 0.6 mm, top 1 mm) was done by adjusting four screws located in the 
bottom chamber (Figs. 3.5 and 3.6). The hole in the guard chamber is funnel shaped to 
accommodate the oocyte without using the vaseline rim. These improvements, already used in 
(85), result in a faster assembling of the system and allows higher reproducibility in seal 
formation.   
A higher and more stable bottom pool support was designed to allow correction of the position 
of internal pipette holder and therefore of the alignment adjustment between (i) the internal glass 
pipette, (ii) the bottom and guard hole and (iii) the oocyte top domus. 
Positioning of the internal perfusion holder was achieved by a linear microcontrol 
alignment positioned at the rear of the bottom pool stage (MT MT-XY and MT-CL, Newport) 
(Fig. 3.6). 
 
Figure 3.6 New design of the COVC system.  
CAD rendering of the new design. The innovations: (i) linear microcontroller; (ii) bottom pool stage; (iii) 
micromanipulator for intracellular perfusion holder are indicated. This gives a good balance between flexibility and 
system stability (courtesy of Institute of Physics, UZH). 
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Perfusion system 
 
The extracellular perfusion flow was driven by gravity and controlled manually via three-
way valves (Fig. 3.7A). The suction was provided by a vacuum pump at a rate that matched the 
inflow rate and, as mentioned above, it can be regulated also during the experiment. 
The internal perfusion system was constructed as shown in Fig. 3.7B. The intracellular 
solution was continuously perfused at the cytoplasmic side of the oocyte membrane via an 
automated delivery dual syringe pump (KD Scientific, Model 100 series). The perfused solution 
was exchanged by means of three-way valves and the flow rate was typically ~5 µl/min (the 
cytoplasmic medium exchange is achieved in ~7 sec).  
 
 
Figure 3.7 Schematic view of the perfusion system. 
Extracellular (A) and intracellular (B) perfusion systems are represented. In the inset is depicted the electrical 
connection between V1 and the internal perfusion system via 3 mM KCl and an agar bridge (3% agar in 3 M KCl). 
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Internal perfusion was achieved using a glass pipette (OD 1 mm, ID 0.58 mm, 
borosilicate glass capillaries, Harvard Apparatus) with a tip diameter of 100 µm tightly mounted 
in a commercially available electrode holder (Warner Instruments), referred to as internal 
perfusion holder. The glass pipette contained two microfilaments in fused silica each with an 
inner diameter of 100 µm (OD 170 µm, TSP100170, BGB Analytic) and cut to a length of ~8 
cm. 
The fused silica capillary tubes were glued to a “Y” piece support (ID 1.19 mm, OD 2.68 
mm, Y barb 1/16in, Ercatech, Switzerland) to obtain maximal stability of the perfusion system 
and to avoid any possible leak of solution, or bubble formation. The “Y” piece was mounted in 
the bottom part of the internal perfusion holder using a 1 mm ID O-ring to prevent solution leak.  
An additional internal solution flushing syringe was connected to the internal perfusion 
holder according to Lausanne design (85). This was necessary to ensure electric contact between 
V1 and the bottom pool. To provide a low resistance contact between the internal solution and V1 
and to avoid contamination from 3 M KCl in the internal solution an agar bridge (3% agar in 3 M 
KCl) was placed between the internal perfusion holder and V1 (inset in Fig. 3.7). 
The internal perfusion holder was mounted on a miniature linear stage (MS series, 
MS500-X, Newport). This was essential to control the penetration of the internal pipette inside 
the oocyte and allow precise positioning just below the upper membrane.  
 
Solutions 
 
The extracellular solutions were the same as for the standard TEVC experiments 
(100Na), composition in mM: NaCl, 100; KCl, 2; CaCl2, 1.8; MgCl2, 1; HEPES-TRIS, 10; 
adjusted to pH 7.4. Pi was added from a 1M K2HPO4/ KH2PO4 (pH 7.4) to the 100Na solution to 
give the desired final concentration of Pi. 
The intracellular solutions were as follows: 100Nai (in mM): NaCl, 100; KCl, 2; MgCl2, 
2.8; EGTA 0.1; HEPES-TRIS, 10; adjusted to pH 7.4. 100Ki (in mM): NaCl, 2; KCl, 100; 
MgCl2, 2.8; EGTA 0.1; HEPES-TRIS, 10, adjusted to pH 7.4. Internal solutions with an 
intermediate [Na+]i and [K+]i were obtained by mixing 100Nai with 100Ki. All the solutions were 
filtered before to be used. 
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Sequence of oocyte mounting 
 
1. Preparation of guard and bottom pools: 
The guard and the bottom pools are both filled with standard extracellular solution 
(100Na). The filling of the bottom pool was made via the hole present in the bottom of the guard 
chamber; this maneuver ensures the electric contact between the two pools by reducing bubble 
formation around the hole. The top pool is also filled with extracellular solution via the 
extracellular perfusion system to prevent the formation of air bubbles. The top pool is lowered 
by the micromanipulator to touch the bottom pool. This maneuver is necessary to correct for any 
possible offset between the electrodes (see point 3).  
2. Preparation of the intracellular system: 
The intracellular syringes are filled with 5 ml of intracellular solutions (i.e. 100Ki) and 
the pump delivery is turned on to completely fill the plastic tubes and the fused capillary to 
eliminate air bubbles. The flushing syringe is also filled with internal solution and is used to fill 
the internal perfusion holder and the glass internal pipette. The pipette is raised through the 
bottom hole  
3. Mounting electrodes and adjustments: 
The electrodes are now positioned in the appropriate slots. In the top pool the agar 
bridges (polyethylene tubes of 1.09 mm OD, 0.38 mm ID filled with a gel made of 3% agar 
solved in 3 M KCl) are connected to the P1 and P2 wires by silicon tube (2 mm OD, 1 mm ID) 
filled with 3 M KCl. The immersion of P1 and P2 in the top bath can cause a small DC offset 
visible in the Im output. This offset can be adjusted by a trim pot in the main head-stage, which 
contains the mains electrical connectors of P1, P2, GS1 and GS2. GS1 and GS2 are now  connected 
and immersed in the guard pool. Correction for voltage offsets is achieved by a regulation of a 
trim pot on the main head-stage as for P1 and P2. GS2 is placed in a diagonal hole drilled in the 
top chamber to be as close as possible to the cell. GS1 was placed in the guard bath. Both guard 
electrodes are constructed as previously described for P1 and P2. In the bottom pool, the I 
Ag/AgCl pellet is used to clamp the inside of the oocyte to zero volts. 
The V2 electrode can be now connected to the head-stage and immersed in the top pool. 
The offset correction is nulled via the Dagan controller. V1 can be connected as previously 
describe in the internal perfusion holder and the offset correction made by a adjustment on the 
Dagan controller.. 
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4. Oocyte mounting: 
The top pool is now lifted to allow the oocyte positioning. The positioning of the oocyte 
in the funnel shaped hole in the guard pool is a critical step. The oocyte has to be gently placed 
in the hole and a negative hydrostatic pressure is applied to fix the oocyte in position. The 
negative hydrostatic pressure is obtained manually by sucking a small amount of solution out of 
the bottom pool with a Pasteur pipette. The oocyte is now in position and has to be orientated in 
the correct way: the animal pole (or dark pole) should face down to improve visual control of the 
position of the internal pipette penetration during the clamp procedure.  
5. Establishment of electrically separate pools:  
The three electrically separate pools are obtained by lowering down the top pool using 
the micromanipulator and gently make contact with the oocyte membrane. This step is critical to 
ensure a stable experiment, because it determines the quality of the seal around of the oocyte 
domus. The top pool can now be re-filled with extracellular solution via the perfusion system 
described above (Fig. 3.7).  
 
Clamp procedure 
 
A test pulse (typically +10 mV) is applied via a membrane test run in the pClamp program or the 
internal test on the Dagan voltage clamp to monitor the different stages in the oocyte positioning 
and penetration.  
When the three electrically separate compartments are ready, the oocyte top domus is 
passively charged via the resistance of the unpermealized membrane in the bottom pool and the 
cytoplasmic resistance in series. The insertion and the positioning of the internal glass capillary 
tip will be visible to the operator both in the microscope (as shaded ring below the oocyte 
membrane) and electrically on the oscilloscope (as change in the capacitive transient relaxation 
speed). The internal pipette tip is raised and the animal pole membrane penetrated. The 
capacitive transients, visualized on an oscilloscope, are now characterized by slow decay 
resulting from the cytoplasmic resistance and the capacitance of the oocyte membrane exposed 
to the top pool.  
The optimal perfusion of the cytoplasmic side of the membrane is obtained by placing the 
intracellular pipette tip in close proximity to the upper domus membrane. The internal pipette 
must be as close as possible to the clamped membrane to minimize the voltage drop due to the 
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electrical resistance of the oocyte cytoplasm. It is now possible to switch the guard clamp from 
passive to active and then the clamp can be turned on (A1), which will result in very fast clamp 
of the upper portion of the oocyte membrane, visible with the oscilloscope by a fast decay of 
capacitive transients, typically <100 µs. 
 
3.2.2  “Substrate interactions in Na+-coupled Pi cotransporters – a cytosolic 
perspective” 
The COVC can be used to characterize changes in NaPi-IIb kinetics in response to 
changing the cytosolic substrate concentrations. This will potentially give new insights into the 
effect on apparent substrate affinities and order of substrate binding/de-binding at the cytosolic 
side. 
The first aim in this work was to establish the quality of the recordable data by means of 
the new system by comparing the records with those obtained using TEVC. 
As shown in Fig. 3.8, IPi was comparable to the TEVC data when the system was 
perfused on both side of the membrane (inside 100Ki, outside 100Na and 100Na + 1mM Pi). The 
IPi was, as expected, smaller than the signal recorded in TEVC, as only ~10 % of the membrane 
is accessible to the external solution exchange. However, a change in the voltage-dependence of 
IPi was observed. This alteration of IPi with respect to IPi recorded with TEVC, might be 
explained by the complete absence of Na+ ions in the intracellular medium.  
 
Figure 3.8 Comparison of phosphate-induced current (IPi) measured with COVC and TEVC. 
A. I/V relationship of IPi obtained with COVC. The substrate-induced current was obtained by subtraction of the 
current recorded in 100Na from the current recorded in presence of 1 mM Pi in the extracellular solution (100Na). 
The oocyte cytoplasm was continuously perfused with the standard 100Ki (100 mM [KCl]i) via internal perfusion. B. 
TEVC IPi I/V data before for the substrate induced current. This record was obtained from an intact oocyte. 
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To confirm this hypothesis more experiments have to be performed using different Na+ 
concentrations in the intracellular perfusion solution. 
One general question that we would like to answer using this technique is: how a change 
in the ionic composition of the intracellular solution modifies the transporter kinetics? 
The standard internal perfusion solution contains potassium (K+) as the main cation (100Ki). In a 
series of experiments, this solution was exchanged with an intracellular solution containing 100 
mM of NaCl (100Nai). Considering NaPi-II, which is a sodium-dependent cotransporter, it is 
possible to envisage an effect on the transport activity due to a cation substitution on the 
cytoplasmic side of the membrane.  
This hypothesis was first tested by determination of the apparent affinity of Pi in presence 
of 100Nai at the cytoplasmic side of the oocyte membrane. From the IPi/[Pi]O relationship fitted 
with the Michaelis-Menten equation (see Fig. 3.9) we estimated the apparent affinity constant for 
phosphate (.JK ).  
 
 
Figure 3.9 Pi dose-response recorded at Vh = -50 mV.  
The two data sets were obtained using TEVC (black squares, n=5) and COVC (open squares, n=3). The data were 
fitted with Michaelis-Menten equation (Eqn. 2.1) and gave  .JK  =f 0.05±0.01 mM (TEVC) and 0.13 ± 0.06 mM 
(COVC). The TEVC records were obtained from intact oocytes whereas with COVC the data were collected from 
internally perfused oocytes (100Nai).  
 
The .JK  obtained with TEVC and COVC with 100Nai were 0.05 ± 0.01 and 0.13 ± 0.06 
respectively. This difference suggests that the intracellular Na+ might influence the internal 
partial reactions in NaPi-II although these are preliminary data. Further experiments, with 
different [Pi]O and several different intracellular solutions must be performed to fully 
characterize the intracellular partial reactions. 
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4. DISCUSSION 
 
 
The detailed characterization of phosphate transport proteins is necessitated by the essential 
role that phosphate plays in the body. The functional mechanism of these proteins has been the 
subject of many studies for more than 30 years. After cloning and heterologous expression of rat 
NaPi-IIa (110), a characterization of the transport kinetics of the wild-type transporter (52, 118) 
was performed. Following the cloning of different isoforms and subtypes together with a large 
number of single point mutational studies (89, 93, 94), the results of two-electrode voltage clamp 
(TEVC), voltage clamp fluorometry (VCF) and radiotracer assays have allowed us to make some 
generalizations about this family of membrane transport proteins. 
Three common features of the NaPi-II isoforms are (53, 159):  
• their amino acid sequences. All the members of the SLC34 family (NaPi-IIa, IIb, and IIc) 
have a high degree of sequence identity. Taking into account the differences in sequence 
length, it is possible to conduct a hydrophobicity analysis, predicting a comparable 
secondary topology model for all three isoforms. The amino acid sequence differences 
appear to be mostly in the C- and N- termini as well as in the large hydrophilic 
extracellular loop (Fig. 2.20). The two halves of the proteins are separated by this large 
loop and show a high degree of similarity in the predicted membrane spanning domains 
(53); 
• their functionally. The apparent affinity for Na+ is ~50 mM for all three isoforms and all 
transporters preferably divalent phosphate with an apparent affinity <0.1 mM Pi. The 
transport can be inhibited by using a competitive blocker: phosphonoformic acid (PFA) 
(159).  
• their common substrate binding order and substrate specificity for electrogenic and 
electroneutral isoforms: Na+, Na+ Pi, Na+ (61, 157).  
These commonalities suggest a similar transport mechanism among the isoforms. 
Nevertheless, there is also one important functional difference between the three isoforms. NaPi-
IIc is electroneutral and therefore 2 Na+ ions together with 1 HPO42- are transported inside the 
cell per transport cycle on the other hand, the electrogenic NaPi-IIb and NaPi-IIa transport 3 Na+ 
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coupled with 1 HPO42-. It was shown that the substitution of three residues with their NaPi-IIa 
equivalents in NaPi-IIc (S189A, S191A, and G195D) resulted in electrogenic transport with a 
ratio of 1:1 charge/Pi coupling, which confirmed the 3Na+:1Pi stoichiometry observed for the 
electrogenic wild-type isoforms (9). 
Two further properties of the electrogenic isoforms that have been addressed in this thesis 
are: (i) the leak mode and (ii) the interaction and participation of Li+ ions in the cotransport 
mode.  
 
4.1 Leak mode in Na+-coupled phosphate transporters 
 
The NaPi-II kinetic scheme (Fig. 2.30, section 2.5.3) incorporates a leak cycle in addition 
to the normal cotransport cycle. The leak cycle was proposed to represent a uniporter transport 
that allows Na+ ions to be translocated according to their electrochemical gradient. In the kinetic 
scheme, the leak shares three partial reactions with the cotransport cycle (10, 88) but does not 
include Pi or the last Na+. Studying the leak mode gives insight into the behavior of a subset of 
partial reactions.  
The Na+-coupled sugar transporter (SGLT1) is an example of a protein with transport 
characteristics similar to NaPi-II. SGLT1 is characterized by both cotransport and leak modes. 
Both SGLT1 and NaPI-II cotransporters are Na+-dependent, yet it is also known that Cl- 
plays a role in the SGLT1 cotransport mode by increasing the apparent affinity for sugar (102). 
Until recently, it was still unclear why the observed reversal potential for the Na+-dependent leak 
current (phlorizin-sensitive leak current) for SGLT1 was approximately -30 mV (155). A recent 
study showed using a mutant that displays a threefold increase in the leak current, that the leak in 
SGLT does not involve Cl-. Moreover, they showed that other monovalent cations can stimulate 
the leak current and shift the Er toward positive potentials (i.e. Li+ ~+ 30 mV) (100). 
Electrogenic isoforms of NaPi-II possess a leak current that is quantified by using 
phosphonoformic acid (PFA) as blocker. PFA is assumed to fully suppress this current. The 
PFA-sensitive current (IPFA), that is believed to be solely due to permeation of Na+ ions, is 
characterized by a reversal potential (Er) that is typically between -30 mV and -20 mV. Like 
SGLT1, this negative Er is inconsistent with Na+ being the only permeant cation (Fig. 4.1). 
Discussion 
133 
 
 
Figure 4.1. I/Vs plot of IPi and IPFA. 
A. and B. PFA-sensitive current (-IPFA, open squares) obtained by subtraction of the current recorded in presence 
100Na and 1mM PFA from the current recorded in 100Na; the normalization refers to the phosphate-induced 
current recorded in 100Na and in response to 1mM Pi at -100 mV. The red arrow indicates the reversal potential 
(Er) for each isoform. The filled squares represent the net substrate-induced current activated by the presence of 
100 mM Na+ and 1 mM Pi (subtraction of the current recorded in 100Na from the current recorded in 100Na + 
1Pi). C. I/V traces recorded in non-injected oocytes superfused with 100Na + 1mM Pi (black squares) or 1 mM PFA 
(open squares). Modified from (6). 
 
My contribution to the investigation about the nature of Er showed, unexpectedly, that for 
V > 0 mV, PFA suppresses an endogenous outward Cl- current (Fig. 4.2).  
This endogenous component can affect our ability to resolve the leak current (-IPFA) and 
IPi in oocytes exhibiting low expression. Variations in the endogenous component were observed 
in different batches of oocytes (cells coming from different donor frogs) as well as according to 
the number of days after injection of oocytes with cRNA.  
I observed that 1 mM PFA was sufficient to block an endogenous Cl- efflux in non-
injected oocytes. This current can be larger than the IPFA in low expressing cells, resulting in an 
inward current that gives rise to a negative Er (Fig. 4.1C). 
 The observation in non-injected oocytes was confirmed in oocytes expressing NaPi-IIa. 
Chloride substitution with the large anion 2-(N-morpholino) ethanesulfonic (MES) as well as 
other anions (glucuronate, methansulfonate, sulfate, and nitrate) did not affect the magnitude of 
IPFA at negative potentials (Fig. 4.2). The suppression of IPFA at positive potentials was evident 
when 100 mM chloride was substituted with 100 mM of MES or glucuronate (Fig. 4.2 left panel) 
in agreement with the findings for non-injected oocytes. 
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Figure 4.2 Anion substitution in rat NaPi-IIa expressing oocytes. 
The currents represented in the figure are normalized for the IPi (in 100Na and 1 mM Pi) at -100 mV. Left panel 
show I/V curves obtained in presence of 100 mM of either MES (upper panel) or glucuronate (lower panel) where 
7.6 mM of Cl- were still present. Right panel summarises the effect of a selection of anion substitutions on the IPFA 
and on IPi. Modified from (6). 
 
The representative I/V for a non-injected oocyte (Fig. 4.1C) confirms that 1 mM PFA can 
also affect endogenous currents. Moreover, a reduction in the external Cl- concentration, from 
107.6 mM to 7.6 mM (Fig. 4.2, open squares) causes a reduction in the apparent inwardly 
directed current at positive potentials. This gives rise to a depolarizing shift in the Er. The data in 
Fig. 4.2 (right panel) confirms that anions, with the exception of guconate, do not change the 
magnitude of IPFA and IPi. 
In the case of gluconate substitution: the IPFA-sensitive is significantly larger than in 
standard condition. Interestingly, concomitant with the IPFA increase, a decrease in IPi was 
observed. Moreover, the resulting total electrogenic activity (ICot = IPi – IPFA) was reduced only 
by 17% (Fig. 4.3). This experiment also confirms the validity of our current model for the mutual 
exclusivity of the leak and the cotransport modes because of the unique effect that gluconate has 
on the leak. In additional experiments, we could show that the voltage-dependence of the leak 
current was similar to that of IPi, supporting our model in which the leak and cotransport modes 
have the same voltage dependent partial reactions. 
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This behavior seems to be unique for NaPi-II transporters. When an experiment was 
performed using SGLT1 as control, gluconate did not affect the leak current even if the 
replacement slightly reduced the cotransport current due to a known involvement of Cl- in the 
cotransport mode of SGLT (102). 
 
 
Figure 4.3 I/Vs gluconate substitution. 
I/V curves obtained in presence of Cl- (squares) and in presence of gluconate (diamonds). Left panel: IPFA (open 
squares) and IPi (filled squares) are added to obtain ICot (gray symbols) values with either Cl- or gluconate. IPFA in 
presence of gluconate (open diamonds) is larger than IPFA in Cl-. ICotgluconate shows only a 17% reduction of ICot in Cl-. 
Right panel: the same experiment performed with SGLT1 and using phlorizin to block the leak. Gluconate does not 
increase the phlorizin-sensitive current (open diamonds), whereas a decrease in the glucose sensitive current can be 
observed (filled diamonds) in comparison to the glucose current recorded in presence of chloride (filled squares). 
Modified from (6). 
 
To investigate the behavior of gluconate in more detail, we tested the hypothesis that a 
reduction of Ca2+ or Mg2+ may influence the IPFA given that gluconate is a well known chelator 
of divalent cations. The hypothesis was tested by performing two experiments. In the first 
experiment, we used a common Ca2+ chelator EDTA (ethylenediaminetetraacetic acid) at 0.5 
mM to mimic the effect of the presence of 100 mM of gluconate and in the second experiment 
we used a solution with a 10-fold lower Ca+ concentration (0.18 mM). In neither experiment we 
could not recapitulate the same behavior of IPFA in presence of gluconate, therefore we could 
reject the divalent chelator hypothesis.   
Another concern using gluconate solution is that it can change its chemical properties. 
We checked freshly prepared solutions containing gluconate by means of nuclear magnetic 
resonance, NMR, spectroscopy (performed in the lab of Prof. Robinson, Institute of Organic 
Chemistry, UZH) for contamination and stability. We obtained resonance frequency spectra for 
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four consecutive days (the normal period where we keep our solutions for the experiments), and 
compared them. No differences in the spectra were found, indicating that the solutions did not 
change their properties.  
From there results we concluded that the sodium gluconate solution was stable at least  
over a short period of time and that the effect on IPFA is not influenced by Ca2+ or Mg2+. As the 
gluconate effect appears to be unique to NaPi-II, we tentatively suggest that it may directly or 
indirectly interact with NaPi-II proteins to increase the translocation rate of Na+ ions in the leak 
mode.  
In both intestine and kidney, the leak mode of NaPi-II most likely has no physiological 
relevance because Pi is always at a high enough concentration so that the cotransport mode is 
favored. However, the Na+-leak mode gives a useful phenotype to understand structure/function 
data. 
 
4.2 Lithium interactions 
 
Since 1946, lithium has been used in the treatment of psychiatric diseases (i.e. bipolar 
disorder (137)). The mechanism of the Li+ action as a mood-stabilizer is still not well 
understood. The therapeutic action can involve several targets in the brain: inhibition of enzymes 
(e.g. glycogen synthase kinase 3, inositol phosphatases), modulation of glutamate receptors, 
modulation of monovalent cations transport (e.g. Na+) (170).  
When ingested, Li+ is absorbed in the gut, distributed via the circulation (from which 
lithium will have access to the brain, its target organ via the blood-brain barrier) and then 
excreted in the urine. The kidney, Li+ is freely filtered in the glomerula and by the time it reaches 
the proximal tubule, 80% is reabsorbed by Na+-dependent transporters (151).  
It has been shown that Li+ influences the kinetics of succinate transport in the renal 
proximal tubule. Using rabbit renal brush border membrane vesicles, in presence of Na+, Li+ acts 
as an inhibitor (Ki of 1.2 mM) of the sodium-dependent succinate transporter (166). 
The transporter was then identified through expression cloning as NaDC-1 (121) and 
characterized in X. laevis oocytes. It was demonstrated that Li+ alone can drive succinate 
transport via NaDC-1 with a lower apparent affinity than for Na+ (122). 
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As Li+ is present in the proximal tubule and can affect the function of renal secondary-
active transporters, we investigated if Li+ also has an effect on Pi handling in the proximal 
tubule? 
Physiological studies have shown that no changes in phosphate reabsorption occurs when 
Li+ is administrated to patients (123) and rats (171). This suggests that both renal phosphate 
cotransporter isoforms, NaPi-IIa and NaPi-IIc are unaffected. However, it was shown that for 
intestinal BBMVs, Li+ alone does support Pi uptake at pH 7.4 (14). This result can now be most 
likely explained by the presence of Type III phosphate cotransporters (PiT-2, SLC20) (11). After 
SLC20 isoforms were cloned and expressed in X. laevis oocytes a significant 32P uptake in 100 
mM LiCl was observed compared with control non-injected oocytes and a small electrogenic 
response was reported in response to 1 mM Pi (129), thus confirming the findings from data 
obtained in BBMVs.  
Using Voltage Clamp Fluorometry (VCF), it was observed that at least one Li+ ion could interact 
with NaPi-IIb. This study involved engineering a novel cysteine at site S448 to allow fluorescent 
labeling (157). In this mutant (S448C), the transport kinetics were similar to the wild type (WT), 
whereas the electrogenic cotransport of Pi was suppressed after exposure to thiol reactive agents 
such as MTS (methanethiosulfonates) (157). It was concluded that, despite the lack of 
cotransport activity, cations and Pi interactions still took place. In the case of labeling with the 
fluorophore, MTS-TAMRA, it was shown that at least one Li+ interacted with the protein with an 
apparent affinity in the range of 100 - 300 mM
 
(157). To further investigate the molecular effect 
of Li+ on NaPi-II, we decided to characterize how the NaPi-II driving cation selectivity and 
transporter kinetics for Pi and Na+ were affected by the presence of Li+. In the next sections the 
figures indicated by * are numbered as in section 3.1.2: “Lithium interactions with the type II 
Na+-coupled inorganic phosphate cotransporters.” 
 
The effect of Li+ substitution on 32P uptake 
 
 Radioactive assays performed using oocytes expressing the electrogenic isoforms of 
NaPi-II showed that Na+ replacement by Li+ in the extracellular medium gave 32P uptake (~3%) 
that was significantly different from when Na+ was substituted with choline (Ch), which we 
assume from previous experiments, does not interact with NaPi-II (*Fig. 1A). The uptake levels 
observed would be expected to give an electrical response of <10 nA. This current is comparable 
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in size to the signal obtained from endogenous currents in non-injected oocyte exposed to a 
solution containing 100Na + 1 mM Pi. Because of these reasons it was not possible to further 
characterize the Pi response in presence of 100 mM Li+ using both radioactive assays and TEVC 
technique.  
It was then decided to use solutions that contained both Na+ and Li+ and compare the 
results with the corresponding Na+ and Ch mix (i.e. 50Na50Li compared with 50Na50Ch). 32P 
uptake data indicated that in presence of Li+ the uptake was decreased by ~50% (*Fig 1B), 
which suggested that Li+ does indeed interact with electrogenic NaPi-II. In contrast, a previous 
study showed that 32P uptake in oocytes expressing the electroneutral NaPi-IIc was not affected 
by the presence of Li+ (50Na50Li compared with 50Na50Ch) (61). Nevertheless, in that study it 
was suggested that one Li+ ion interacted with NaPi-IIc protein in an electroneutral manner. 
These apparently contradictory results can be explained by taking into account the hypothesis 
formulated in the context of that study (61). In NaPi-IIc, where 2 Na+ ions are transported with 1 
Pi, it was proposed that 3 Na+ ions bind to the protein, but the first of these to interact does not 
participate in the transport cycle. It can be hypothesized that the first Na+ binding can be affected 
by Li+ ions. To obtain more evidence in support of this hypothesis, we investigated the effect of 
Li+ on the electrogenic isoforms of NaPi-II cotransporters. These experiments were undertaken 
using mainly the NaPi-IIb isoform because of the robust Pi-induced currents (> -200 nA range at 
-50 mV) when expressed in X. laevis oocytes. 
 
Steady-state electrophysiology 
 
 First, we studied the effect of equimolar replacement of Na+ with either Li+ or choline 
chloride on the phosphate induced current (IPi) activated by 1 mM Pi. In presence of Li+, IPi was 
always smaller than in the corresponding Na+ substitution with Ch at hyperpolarizing potentials 
(i.e. -100 mV, Fig. 4.4A). When referred to IPi at -100 mV in 100Na, we found a decrease of 
~25% in presence of 50Na50Ch and a decrease of ~50% in IPi in presence of 50Na50Li. This 
result was confirmed also by using another NaPi-II isoform (i.e. hNaPi-IIa, Fig. 4.4B) even 
though the reduction in IPi was quantitatively different (~25% decrease in ChCl and ~30% in 
LiCl). Furthermore, for both isoforms the presence of Li+ strongly affected the voltage-
dependence of IPi, making the I/V relationship less voltage dependent in the presence of Li+ for 
V<0 mV. This was most readily seen for the flNaPi-IIb isoform (see Fig 4.4A) and this was even 
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more pronounced when 75 mM Na+ was replaced with Li+: the voltage-dependence of IPi for 
flNaPi-IIb isoform was completely suppressed for V<0 mV (*Fig. 2A). 
From these steady-state electrophysiology findings, we drew the following conclusions: 
1) the “Li+ effect” was most likely general with respect to electrogenic members of the 
SLC34 family; 
2) Li+ substitution had a significant effect on the voltage-dependence and the rate limiting 
cotransport activity at hyperpolarizing V; 
3) in the presence of Na+ and Li+, the electrogenicity of transport is maintained.  
 
 
Figure 4.4 Effect of Li+ on IPi recorded in oocytes expressing. 
I/Vs relationships obtained in three different perfusion solution as indicated. A. flNaPi-IIb isoform and B. hNaPi-IIa 
isoform. 
 
 These findings suggest that the previously identified voltage-dependent partial reactions 
(1 ↔ 2a and 8 ↔ 1, see Fig. 4.6) could be affected by the presence of Li+ in the extracellular 
solution. Nevertheless, as these data were obtained at only one Pi concentration and with two Na+ 
concentrations, we were unable to characterize the Li+ effect. It is possible to hypothesize that 
Li+ affects (i) the voltage-dependence partial reactions of the cotransport cycle alone, or (ii) it 
has an additional effect on the translocation of the fully loaded carrier, which has been 
hypothesized to be the rate limiting step in the transport cycle for NaPi-II protein. 
To gain further insight into the specific partial reactions influenced by Li+ we determined 
the apparent affinities for each substrate. Steady-state currents were recorded during perfusion of 
the oocytes with a solution containing 50 mM Li+ and 50 mM Na+ and different concentrations 
of Pi to study Pi-activation in presence of Li+. From the data analysis (data fitted with Michaelis-
Menten equation, Eqn. 2.1 with nH=1) we obtained the apparent affinity (K0.5Pi) and the maximal 
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response for Pi (IPimax). We showed that IPimaxLi was reduced compared to the IPimaxCh (*Fig. 3C). 
The voltage-dependence of IPimax was weaker for V<0 mV, confirming the data Fig. 4.4. The 
K0.5Pi obtained in 50Na50Li was lower compared to the K0.5Pi in 100Na and in 50Na50Ch for -
100 mV < V < 0 mV (*Fig. 3D).  
From these data, we concluded that in presence of Li+, the apparent affinity of Pi for 
NaPi-II increased, which suggested that Li+ interacts with NaPi-II and thereby changes the 
distribution of transporter state occupancies such that it is easier for Pi to bind to NaPi-II. This 
suggestion led to the formulation of two hypotheses: (i) Li+ binds to the protein allosterically and 
can also change the Na+ apparent affinity or (ii) Li+ substitutes for Na+ and is translocated during 
the cotransport cycle.  
To decide between the two hypotheses the next question to be answered concerned the 
Na+ interaction in presence of Li+. Particular attention was paid to the prediction of the Hill 
coefficient (nH) and the apparent affinity for Na+ because we had already observed an alteration 
in K0.5Pi in 50Na50Li. The result of the Na+ activation experiment showed a variation in nH in 
the 50Na50Li solution. The coefficient was found to be close to 1, whereas in absence of Li+ the 
prediction gave an nH > 2 (*Fig. 4C). This result suggested that the presence of Li+ changes the 
cooperativity of Na+ binding to the transporter. Moreover, K0.5Na+ was reduced in the presence of 
Li+ (*Fig. 4D). The behavior of the phosphate response in the complementary experiment, where 
the Li+ concentration was changed in presence of 50 mM Na+ (nH ~1, and K0.5Li+ ~25 mM, *Fig. 
5C) suggested that at least one Li+ could interact with NaPi-II.  
From additional experiments (not shown), in which we kept the concentration of Na+ (50 
mM) constant and changed the Li+ concentration (25 mM and 50 mM) we concluded that Li+ 
was not the last ion to interact with NaPi-II based on the observation that no Li+-dependent Imax 
was observed. 
From these results, we concluded that the interaction of at least one Li+ ion changes both 
K0.5Na+ and K0.5Pi, which indicated that the kinetics of the transporter change in presence of Li+. It 
was not possible from these data to identify which partial reactions of the kinetic scheme were 
modulated by Li+, or, according to our second hypothesis, if Li+ can substitute for Na+ at least in 
one of the partial reactions.  
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Simultaneous electrophysiology and uptake assays 
 
Simultaneous electrophysiology and uptake experiments with 22Na showed a decrease in 
the ratio of the number of moles of Na+ (nNa+) transported to the molar equivalent of charge 
translocated (nQt) in presence of Li+.  
Solution nNa+/ nQt 
40Na60Ch 3.1 ± 0.5 
20Na80Ch 2.8 ± 0.5 
40Na60Li 2.2 ± 0.13 
20Na80Li 1.6 ± 0.23 
Table 4.1 Na+ to charge ratio obtained by simultaneous electrophysiology and uptake assays. 
Values from *Fig. 6A and B. 
 
This result supports the hypothesis that at least one Li+ ion can substitute Na+ in the 
transport cycle at high Li+ concentrations. Our findings do not fully exclude the possibility that 
more than one Li+ ion can participate in a fraction of the transport cycles, because the Hill 
coefficient (nH) predicts the lower number of ions that interact in a cooperative manner with the 
transporter.  
 
Na+- and Li+- dependence of presteady-state kinetics 
 
From steady-state data analysis we saw that the voltage dependence of IPi was strongly 
affected by the presence of Li+, nevertheless, some electroneutral partial reactions could also be 
influenced by Li+. This led us to investigate in detail the partial reactions that precede Pi binding, 
namely the empty carrier (8 ↔ 1) and the two Na+ binding partial reactions (1 ↔ 2a and 2a ↔ 
2b) (Fig. 4.5). The kinetics of these partial reactions can be investigated by removing Pi from the 
external medium and applying voltage steps to evoke presteady-state charge movements. 
The presteady-state analysis showed that like Na+ ions, Li+ ions were also able to interact 
with the transporter in a voltage dependent manner (*Fig 7B). However, the total charge 
movement with 100 mM LiCl was approximately 70% of that obtained in 100 mM NaCl and the 
shift in the midpoint voltage of the steady-state Q-V distribution (V0.5) with changing [Li+] 
suggested that only one Li+ ion interacted with the protein as opposed to 2 Na+ ions. 
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One possible explanation for the reduced Qmax is that the Li+ ions do not enter as deeply 
into the transmembrane electric field as Na+ ions. A second hypothesis takes into account that, in 
absence of Na+, we are observing at only two partial reactions (8 ↔ 1 and 1 ↔ 2a) as only one 
Li+ is interacting with NaPi-II before the Pi. The partial reaction 2a ↔ 2b were also electrogenic, 
the Qmax reduction in Li+ alone can be explained by the fact that this transition does not take 
place. Compelling evidence that supports the second hypothesis is that when both Li+ and Na+ 
are present the Qmax50Na50Li is equal to Qmax100Na, thereby compensating for the charge missing in 
100Li. Given that the maximum charge obtained in 50Na is approximately the same as in 100Na 
(*Fig. 8), if Li+ can contribute to the charge movement at a site independent of the Na+ site, we 
would expect that in 50Na50Li Qmax would be larger. That this was not the case strongly 
suggests that Li+ ions and Na+ ions have common interaction site(s). 
In the 50Na50Li solution we observed significantly slower time constants for the 
presteady-state currents compared to those obtained in a Li+-free solution, particularly for 
voltage steps >0 mV (*Fig. 7C). Under these conditions, the time course of the presteady-state 
currents was best described by two time constants, one of which was in the same range (<10 ms) 
as normally observed for Na+ alone and a second, the slower time constant, typically >15 ms. 
Importantly, the total displaceable charge was the same as when only Na+ was present. This 
suggested that the number of cations contributing to the total charge movement when both Na+ 
and Li+ were in the medium was the same as when Na+ alone was present. The slower time 
constant for charge movement observed for depolarizing steps suggested that if both Li+ and Na+ 
were bound, the presence of Li+ slowed the overall release of bound charge from the protein.  
To investigate the nature of Na+-Li+ interactions in more detail, we examined the 
presteady-state currents with varying [Li+ ] or [Na+] in the presence of a fixed concentrations of 
Na+ or Li+, respectively. When Na+ was the variable cation, the slope of V0.5 with respect to 
log10[Na+] was always significantly < 80 mV/decade except when [Li+]=0. This suggested that 
Li+ suppressed the normal interaction of 2 Na+ ions that gives rise to a slope of approximately 
120 mV/decade (*Fig. 9D). In the complementary set of experiments with Li+ the variable 
cation, the slope remained approximately 60-70 mV/decade, consistent with one Li+ interacting 
with NaPi-II (*Fig 10C). 
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Proposed kinetic model 
 
A revised kinetic scheme is proposed to take account of the above results in which two 
cotransport cycles are possible depending on the presence or absence of Li+. 
The current model proposes that Li+ and Na+ compete for the same binding site (s) (at 
least one) in the protein. Depending on the concentration of both cations (i.e. Na+ and Li+), the 
probabilities to complete either the “all-Na+-NaPi-II cotransport cycle” or the “Li+-Na+ 
cotransport cycle” change, depending on the concentration of both cations. If Li+ is present at 
high concentration the probability cotransport via the “Li+-Na+ cotransport cycle” (left cycle in 
Fig. 4.5) increases and therefore Li+ will bind first followed by one Na+. If Pi is present, the 
transport cycle proceeds and all substrates (1Li+, 1Na+ 1HPO42-, 1 Na+) can translocate across the 
membrane. However, there is always a possibility for Na+ to bind in the first Na+ binding site 
and the cotransport via the conventional cotransport cycle, “all-Na+-NaPi-II cotransport cycle” 
(right-hand loop in Fig. 4.5), will occur. To test the feasibility of this scheme, numerical 
simulations will be necessary.  
 
 
Figure 4.5 Current cotransport kinetic scheme of NaPi-IIb.  
 
In summary, the experiments performed have provided compelling evidence in support of  
Li+ ions acting as a substitute for at least for one Na+ ion in the cotransport cycle and that their 
presence can significantly alter the voltage-dependence of the transport kinetics, as well as the 
maximum transport rate. Recent evidence from uptake experiments performed using the 
electroneutral NaPi-IIc strongly support the notion that Li+ interacts only with the first cation 
binding site (61). In that study, it was suggested that although 2 Na+ ions most likely interact 
with the protein before the Pi, only one of these (corresponding to partial reaction 2a↔2b in the 
scheme of Fig 4.5) participates in cotransport. For NaPi-IIc, evidence for Li+ interactions was 
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obtained from voltage clamp fluorometry assays, however the apparent affinity estimated from 
the fluorometry assays for Li+ was even higher than that obtained from similar assays performed 
using the S448C mutant of the electrogenic NaPi-IIb (157). 
 
4.3 Future perspectives 
 
Two functional aspects of Na+-coupled phosphate cotransporters have been investigated in 
this dissertation.   
The ionic nature of the leak mode in NaPi-IIa/b has been studied with respect to a potential 
anion conduction. More information could be obtained by using COVC to gain further insight 
into the reversibility of the PFA-sensitive current by using mutants characterized by a larger IPFA. 
In this study, it was not possible to clarify whether Li+ ions were able to activate the leak mode 
on NaPi-IIa/b. The size of IPFA was not sufficient to give a clear result. The use of mutants that 
show a bigger PFA-sensitive responce will then be useful to resolve this question. The ability of 
NaPi-II to interact with Li+ ions rise some questions about the Na+ binding sites that cannot be 
answered simply by functional studies. It will be necessary to have a 3-D structure of NaPi-II to 
first confirm the data obtained experimentally (i.e. it Li+ occupies the 1st cation binding site) and 
second to clarify if one Li+ ions can bind at more than one site. Therefore, the 3-D structure will 
give insight into the selectivity of the Na+-binding sites, thereby opening the way to combine 
functional and structural data into a more precise structural model of NaPi-II. 
Mechanistically, it is still not well understood how the intracellular release of substrates 
occurs due to the poor accessibility to the cytoplasmic face of the plasma membrane. By means 
of Cut-Open Voltage Clamp technique, it will be possible to learn about the substrate and co-
substrates internal interaction. Evidence (e.g. human serotonin transporter (4)) suggests that 
changing the internal solute concentration modifies the steady-state and presteady-state 
characteristics. A complete set of functional experiments will be therefore necessary and useful 
to complete and fulfill the gaps in the knowledge about the internal (or cytoplasmic) partial 
reactions giving a final kinetic scheme of NaPi-II transporters.  
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